Peripheral nervous system disorder
MONDO:0003620A disease involving the peripheral nervous system.
Also known as: PNS (peripheral nervous system) diseases, PNS disease, PNS diseases, disease of peripheral nervous system, disease or disorder of peripheral nervous system, disorder of peripheral nervous system, disorder of the peripheral nervous system, peripheral nervous system disease
1942 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New hope for rare bone cancer: targeted drug added to chemo in major trial
Disease control OngoingThis study tests whether adding a targeted drug called ganitumab to standard chemotherapy helps people with newly diagnosed Ewing sarcoma that has spread. The trial includes 312 participants and aims to see if the combination improves survival without the cancer growing back. The…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Experimental drug tazemetostat offered to patients with rare, aggressive tumors
Disease control NO_LONGER_AVAILABLEThis expanded access program provides tazemetostat, a drug that blocks a protein called EZH2, to adults with serious or life-threatening solid tumors that have lost the INI1 or SMARCA4 protein. Eligible patients must have tried other treatments without success and cannot join a f…
Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New shot could ease droopy eyelids in rare muscle disease
Disease control OngoingThis study tests a drug called efgartigimod for adults with ocular myasthenia gravis, a condition that causes eye muscle weakness like droopy eyelids or double vision. About 141 people will receive either the drug or a placebo for 7 weeks, then everyone gets the drug for up to 2 …
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Kids' brain tumor drugs tested for Long-Term safety
Disease control OngoingThis study follows 165 children who previously took dabrafenib and/or trametinib for certain brain tumors. Researchers want to see if these drugs are safe over the long term and how they affect growth. The children continue their treatment and are monitored for side effects and d…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Experimental gene therapy aims to halt devastating brain disease in infants
Disease control TerminatedThis study tests a gene therapy called PBKR03 for babies with early infantile Krabbe disease, a severe genetic disorder that damages the brain and nerves. The treatment delivers a working copy of the GALC gene to the brain and body. Researchers will check safety and find the best…
Phase: PHASE1, PHASE2 • Sponsor: Gemma Biotherapeutics • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Daily injection shows promise for Long-Term control of rare muscle disease
Disease control OngoingThis study tests the long-term safety and effectiveness of zilucoplan, a daily injection, in people with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. About 200 participants who completed a prior zilucoplan trial will receive the drug for an extend…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug hope for kids with rare Muscle-Weakening disease
Disease control OngoingThis study tests a drug called rozanolixizumab in 12 children aged 2 to 18 with moderate to severe generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see if the drug is safe and helps control symptoms. Participants receive injections, and resea…
Phase: PHASE2, PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for kids with NF1 brain tumors: targeted drug may beat chemo
Disease control OngoingThis study compares a targeted drug called selumetinib to standard chemotherapy (carboplatin/vincristine) in children aged 2 to 21 with neurofibromatosis type 1 (NF1) and low-grade glioma, a type of brain tumor. The goal is to see if selumetinib works as well or better at control…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
CAR-T therapy targets autoimmune diseases, but trial never started
Disease control TerminatedThis study planned to test a new CAR-T cell therapy called LCAR-AIO in adults with relapsed or treatment-resistant neurological autoimmune diseases, including multiple sclerosis and myasthenia gravis. The goal was to check safety and find the right dose. However, the trial was wi…
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New pill could slow MS relapses and disability
Disease control OngoingThis Phase 3 trial tests whether the oral drug remibrutinib works better than teriflunomide at reducing relapses and slowing disability in people with relapsing multiple sclerosis. About 1,000 adults aged 18–55 with active MS are taking part. The study is double-blind, meaning ne…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for kids with rare cancers: targeted drug selpercatinib tested in phase 2 trial
Disease control OngoingThis phase 2 trial tests the drug selpercatinib in children and young adults (ages 1 to 21) with advanced cancers that have a specific genetic change called a RET alteration. The goal is to see if the drug can shrink tumors or stop them from growing. Only one participant has been…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Stem cell transplant offers new hope for kids with rare immune diseases
Disease control OngoingThis study tests a donor stem cell transplant for people with severe immune system problems, like SCID and Wiskott-Aldrich syndrome. The goal is to help the body make healthy blood cells and fight infections. Participants receive donated stem cells to rebuild their immune system.…
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug targets Cancer's fuel supply in rare genetic tumors
Disease control OngoingThis phase II trial tests a drug called telaglenastat (CB-839) in people with advanced solid tumors that have specific genetic changes, including NF1 mutations and malignant peripheral nerve sheath tumors. The drug works by blocking an enzyme that cancer cells need to grow. Resea…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug ALXN1720 aims to ease muscle weakness in myasthenia gravis
Disease control OngoingThis phase 3 trial tests whether ALXN1720 can improve daily living and muscle strength in adults with generalized myasthenia gravis who have specific antibodies. About 260 participants will receive either the drug or a placebo for 26 weeks. The study is active but no longer recru…
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Promising drug may shrink inoperable tumors in kids with rare genetic condition
Disease control OngoingThis study tests a drug called selumetinib in children and young adults (ages 3-18) with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink or slow the growth of these tumors. Participants take the dru…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a common MS drug help people with a rare nerve disease walk better?
Disease control OngoingThis clinical trial is testing whether dimethyl fumarate, a drug already used for multiple sclerosis, can improve balance and walking in adults with adrenomyeloneuropathy (AMN), a rare nerve disease. Forty participants will take either the drug or a placebo daily for 36 months, w…
Phase: PHASE2, PHASE3 • Sponsor: Pujol, Aurora, M.D. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for kids with resistant tumors: drug combo enters safety trial
Disease control OngoingThis early-stage study tests a combination of two drugs, avutometinib and defactinib, in children and young adults (ages 3 to 30) with advanced or recurrent solid tumors that have specific genetic changes. The main goal is to find the safest dose with the fewest side effects. The…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug riliprubart tested for Long-Term control of nerve disease CIDP
Disease control ENROLLING_BY_INVITATIONThis study is a long-term extension of earlier trials testing the drug riliprubart in adults with CIDP, a condition where the immune system attacks the nerves, causing weakness and numbness. About 300 participants who completed a prior riliprubart study will continue receiving th…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for myasthenia gravis: experimental drug CNP-106 enters human trials
Disease control OngoingThis study tests an experimental drug called CNP-106 in 54 adults aged 18-75 with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to check if the drug is safe and how it affects the immune system. Participants receive either CNP-106 or a placeb…
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug DNTH103 aims to tame muscle weakness in myasthenia gravis
Disease control OngoingThis Phase 2 study tests a drug called DNTH103 (claseprubart) in 65 adults with generalized myasthenia gravis, a condition that causes muscle weakness. Participants receive either the drug or a placebo, first through an IV and then as injections under the skin every two weeks for…
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug batoclimab aims to ease muscle weakness in myasthenia gravis
Disease control OngoingThis phase 3 trial tests batoclimab, a drug that blocks certain antibodies, in 240 adults with generalized myasthenia gravis (gMG). The study measures if batoclimab improves daily activities and muscle strength compared to a placebo. Participants receive injections weekly or bi-w…
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug hope for rare nerve cancer: tazemetostat under study
Disease control OngoingThis phase 2 trial tests the drug tazemetostat in 10 people with recurrent, treatment-resistant, or metastatic malignant peripheral nerve sheath tumors (MPNST), a rare and aggressive cancer. Participants take tazemetostat pills twice daily for up to 2 years. The main goal is to s…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a drug stop amyloid damage after a heart transplant?
Disease control OngoingThis study tests whether the drug tafamidis can safely stop the progression of ATTR amyloidosis in people who have already received a heart transplant. About 25 stable patients will take tafamidis daily for 12 months. Researchers will measure changes in blood protein levels, nerv…
Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug cocktail aims to outsmart resistant ovarian cancer
Disease control OngoingThis Phase 2 trial tests two experimental drug combinations in 63 women with a specific type of ovarian cancer (BRCA-mutant or HRD-positive) that has worsened after prior PARP inhibitor treatment. Participants receive either tuvusertib plus niraparib or tuvusertib plus larteserti…
Phase: PHASE2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can immune therapy IVIG calm long COVID's autonomic storm?
Disease control OngoingThis study tests whether intravenous immunoglobulin (IVIG) can reduce symptoms of autonomic dysfunction—such as dizziness, rapid heartbeat, and fatigue—in people with long COVID. Two hundred participants will receive either IVIG or a placebo (saline) for 9 months, plus coordinate…
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for acoustic neuroma: direct brain infusion of avastin in early trial
Disease control TerminatedThis early-phase trial tests whether delivering the cancer drug bevacizumab (Avastin) directly into the brain's arteries can safely treat vestibular schwannoma (acoustic neuroma), a non-cancerous tumor that can cause hearing loss. The study enrolls up to 30 adults with growing tu…
Phase: PHASE1 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gene therapy after stem cell transplant shows promise for rare brain disease
Disease control OngoingThis study tests a one-time gene therapy infusion (FBX-101) given after a standard stem cell transplant in 6 children with infantile Krabbe disease, a severe genetic disorder affecting the nervous system. The therapy uses a harmless virus to deliver a working copy of the GALC gen…
Phase: PHASE1, PHASE2 • Sponsor: Forge Biologics, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gut feeling: personalized bacteria may ease PTSD symptoms
Disease control OngoingThis study looks at whether giving people with PTSD a personalized mix of gut bacteria (called pharmabiotics) can help their mental health. The researchers will track changes in PTSD symptoms, anxiety, depression, and thinking skills over 14 days. The goal is to see if fixing the…
Phase: NA • Sponsor: Uzhhorod National University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for SMA patients in major trial
Disease control OngoingThis study tests whether adding taldefgrobep alfa to standard SMA treatments can improve muscle function in people with spinal muscular atrophy (SMA). About 269 participants, both walkers and non-walkers, will receive either the drug or a placebo for 48 weeks. The main goal is to…
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gene therapy hope for SMA kids: early trial launches
Disease control OngoingThis early-stage trial tests a new gene therapy called NKG001 in 21 children under 5 with spinal muscular atrophy (SMA). The therapy is given as a single dose, either through a vein or combined with a spinal injection. The main goal is to check safety and find the best dose, not …
Phase: NA • Sponsor: Nikegen Pharmaceutical (Hangzhou) Company Limited • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill could tame MS relapses
Disease control OngoingThis Phase 3 trial tests remibrutinib, an oral tablet, against teriflunomide in 1000 adults with relapsing multiple sclerosis. The goal is to see if remibrutinib better reduces yearly relapse rates and delays disability. Participants will then have the option to continue remibrut…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Promising drug for rare nerve disease trial pulled before start
Disease control TerminatedThis study was designed to test whether the drug govorestat could improve symptoms of Charcot-Marie-Tooth disease caused by sorbitol dehydrogenase deficiency (CMT-SORD), a rare nerve condition. It planned to enroll people aged 16 to 65 and compare govorestat to a placebo over 36 …
Phase: PHASE3 • Sponsor: Applied Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental combo targets Hard-to-Treat lung cancer
Disease control OngoingThis study tests a new drug, Tuvusertib, combined with an immunotherapy called Cemiplimab in people with a specific type of advanced lung cancer (non-squamous non-small cell) that has worsened after prior treatments. The trial aims to see if the combination can shrink tumors and …
Phase: PHASE1, PHASE2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Engineered immune cells take on rare Muscle-Weakening disease
Disease control OngoingThis early-phase study tests a new treatment called SENL103 for people with refractory generalized myasthenia gravis, a condition that causes severe muscle weakness. The treatment uses the patient's own immune cells, modified to target and destroy harmful cells that attack the mu…
Phase: PHASE1 • Sponsor: Ting Chang, MD • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for stubborn nerve disorder: drug combo shows promise
Disease control OngoingThis study tests whether adding telitacicept to standard therapy helps adults with refractory chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve condition that causes weakness and numbness. About 76 participants will receive either standard care alone or standard c…
Phase: NA • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug aims to replace IVIg for nerve disease
Disease control OngoingThis study tests if a new drug, empasiprubart, works as well as standard IVIg treatment for adults with multifocal motor neuropathy (MMN), a condition that causes muscle weakness. About 154 people who have responded to IVIg in the past will be randomly assigned to receive either …
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Engineered immune cells take on rare Muscle-Weakening disease
Disease control OngoingThis early-stage study tests a new treatment called CABA-201 for people with generalized myasthenia gravis, a condition that causes severe muscle weakness. The therapy uses a patient's own immune cells, modified to target and destroy faulty immune cells that attack the body. The …
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New neck implant aims to improve bone healing and reduce swallowing issues
Disease control ENROLLING_BY_INVITATIONThis study compares a new implant with special nanoLOCK technology to standard implants used in neck fusion surgery. The goal is to see if the new implant helps bones heal better and causes fewer swallowing problems. About 200 adults with neck pain or nerve issues will be randoml…
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New study tracks Selumetinib's Real-World impact on kids with NF1 tumors
Disease control OngoingThis study follows about 80-100 Chinese children aged 3-16 with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas. All participants take the drug selumetinib (Koselugo) and are monitored for 24 months to see how well it works and what side ef…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for NF1 patients: targeted drug shrinks inoperable tumors in early trial
Disease control OngoingThis study tests a drug called selumetinib in 32 Chinese children and adults with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be surgically removed. The goal is to check the drug's safety and how well it works at shrinking these tumors. Participants take the …
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a cochlear implant bring back hearing after tumor removal?
Disease control OngoingThis study tests whether a cochlear implant can safely and effectively restore hearing in people who become deaf in one ear after surgery to remove a benign tumor (vestibular schwannoma) or to treat Meniere's disease. Fifteen participants will receive the implant during their sur…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug aims to ease daily struggles of myasthenia gravis patients
Disease control OngoingThis study tests a drug called inebilizumab in 238 adults with myasthenia gravis, a condition that causes muscle weakness. The main goal is to see if the drug improves patients' ability to do daily activities over 26 weeks compared to a placebo. Participants must have specific an…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New combo shows promise for rare adrenal cancers
Disease control OngoingThis study tests whether adding olaparib to the standard chemotherapy temozolomide helps control advanced pheochromocytoma or paraganglioma—rare neuroendocrine tumors that have spread or can't be removed surgically. About 46 adults with these cancers will be randomly assigned to …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for kids with rare muscle disease: Long-Term drug safety trial begins
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a daily injection called zilucoplan in children with a rare muscle-weakening disease called generalized myasthenia gravis. It includes up to 8 children who have already completed a previous study. The goal is to see if the drug remains …
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Exercise after nerve surgery: hope for arm recovery, but trial pulled
Disease control TerminatedThis study was designed to test whether a daily handgrip exercise program could speed up nerve regrowth and restore muscle and bone after brachial plexus injury surgery. It planned to enroll adults aged 18–60 with confirmed nerve damage. However, the trial was withdrawn before an…
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug combo aims to ease nerve pain in rare blood disorder
Disease control OngoingThis phase 2 trial tests whether the drug zanubrutinib, combined with standard rituximab, can improve nerve damage and disability in people with a rare blood condition called IgM MGUS. The study includes 35 adults across two Dutch hospitals. Participants take zanubrutinib daily f…
Phase: PHASE2 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for kids with rare muscle disease: rozanolixizumab safety trial expands
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called rozanolixizumab in children aged 2 and older with generalized myasthenia gravis, a condition that causes muscle weakness. The drug is given in 6-week treatment cycles. The main goal is to track serious side effects and see…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug shows promise for shrinking painful NF1 tumors
Disease control OngoingThis study tests a drug called mirdametinib in 114 adults and children with a genetic condition called NF1 that causes nerve tumors (plexiform neurofibromas) that cannot be removed by surgery and cause serious problems. The drug works by blocking a protein that helps tumors grow.…
Phase: PHASE2 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Engineered immune cells take aim at childhood cancers in early trial
Disease control OngoingThis early-phase study tests a personalized cell therapy for children and young adults (up to age 26) with solid tumors that have come back or not responded to standard treatment. The therapy uses the patient's own immune cells, modified to recognize and attack a protein called B…
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Early access to experimental SMA drug apitegromab offered before approval
Disease control NO_LONGER_AVAILABLEThis expanded access program provides apitegromab, an experimental drug that blocks myostatin to help maintain muscle strength, to eligible patients with spinal muscular atrophy (SMA) before it is officially approved. Participants must be at least 2 years old and have a confirmed…
Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could a cancer drug shrink Children's brain tumors?
Disease control OngoingThis phase 2 trial tests the drug trametinib in children and young adults (ages 1 month to 25 years) with low-grade glioma or plexiform neurofibroma that has not responded to prior treatment. Participants take a daily oral dose for up to 18 cycles. The study aims to see if the dr…
Phase: PHASE2 • Sponsor: St. Justine's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug tested for Long-Term safety in kids with rare muscle disease
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of efgartigimod in children with generalized myasthenia gravis, a disease that causes muscle weakness. The 12 participants are kids who already took part in earlier studies of this drug. They will continue to receive efgartigimod either th…
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo shows promise for Hard-to-Treat sarcomas
Disease control OngoingThis study tests whether combining two drugs, lenvatinib and pembrolizumab, can safely shrink or control advanced soft tissue sarcomas that have spread or can't be removed by surgery. About 52 adults with specific sarcoma types will receive the combination. The goal is to measure…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cancer drug shows promise for rare blood vessel disorders in kids and young adults
Disease control OngoingThis study tests the drug alpelisib, already approved for some breast cancers, in people aged 2 months to 30 years with certain blood vessel growth disorders caused by PIK3CA or TIE2 gene changes. Participants take the drug for 2-3 years and attend up to 16 clinic visits to check…
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Promising drug trial for kids with rare Muscle-Weakening disease
Disease control OngoingThis study tests a drug called ravulizumab in 12 children aged 6 to 18 with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. The goal is to see how the drug works in the body and if it helps control symptoms. Participants receive the drug through an I…
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Experimental spinal injection aims to keep kids with rare disease moving
Disease control OngoingThis study tests a drug called SHP611, given as a spinal injection, in 36 children with late infantile metachromatic leukodystrophy (MLD), a rare and severe brain disease. The main goal is to see if the treatment helps children keep their ability to walk and move for as long as p…
Phase: PHASE2 • Sponsor: Shire • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug mimics natural protein to calm overactive immune system in nerve disease
Disease control OngoingThis Phase 2 trial is testing a new drug called NVG-2089 in 60 adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a condition where the immune system attacks nerves. The drug is designed to mimic a natural protein (IVIg) to reduce inflammation and improve nerve…
Phase: PHASE2 • Sponsor: Nuvig Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Hope for rare brain disease: new drug aims to slow MSA
Disease control OngoingThis study tests an experimental drug called Lu AF82422 in 64 people with multiple system atrophy (MSA), a rare and serious brain disease. The goal is to see if the drug can slow down the worsening of symptoms like movement problems and daily living difficulties. Participants rec…
Phase: PHASE2 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Last chance access: vatiquinone for mitochondrial disease patients
Disease control NO_LONGER_AVAILABLEThis program offered vatiquinone, an experimental liquid medication, to patients with inherited mitochondrial diseases like Leigh syndrome who had already completed a previous safety study. The goal was to continue treatment for those who might benefit, but enrollment is now clos…
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Gene therapy for ear tumors: Long-Term safety under review
Disease control ENROLLING_BY_INVITATIONThis study follows 100 people with vestibular schwannoma (a non-cancerous ear tumor) who previously received a gene therapy called AAVAnc80-antiVEGF. Researchers will monitor for late side effects and measure tumor size changes over time using MRI scans. The goal is to understand…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Fish oil and Aspirin-Like drug may ease diabetic nerve pain
Disease control OngoingThis early study tests whether fish oil, alone or with salsalate (an anti-inflammatory drug), can improve blood markers linked to nerve health in people with type 2 diabetes and diabetic neuropathy. About 100 adults will take fish oil capsules for 4 months, then add salsalate for…
Phase: PHASE1, PHASE2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug shows promise for stubborn cancers
Disease control OngoingThis study tests a new drug called 9-ING-41, given alone or with chemotherapy, in adults with cancers that have not responded to standard treatments. The goal is to see if the drug is safe and can help control the disease. About 350 people with various advanced cancers, including…
Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a common drug help kids with rare leigh syndrome?
Disease control ENROLLING_BY_INVITATIONThis study tests the drug sirolimus (rapamycin) in 15 people aged 6 months to 55 years with genetically confirmed Leigh syndrome, a rare and serious mitochondrial disease. The goal is to see if the drug is safe and can help with symptoms like muscle weakness and developmental del…
Phase: PHASE2 • Sponsor: Matthew Demczko • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for rare cancers? drug combo shows promise in early trial
Disease control OngoingThis phase 2 study tests two drugs, sunitinib and temsirolimus, in 137 people with advanced rare tumors that have no cure. The goal is to see if these drugs can shrink tumors or slow their growth. Participants take one of the two drugs, and researchers measure how long the cancer…
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for NF1 patients: drug trial targets painful tumors
Disease control OngoingThis study tests the drug selumetinib in adults with neurofibromatosis type 1 (NF1) who have painful, inoperable nerve tumors called plexiform neurofibromas. About 145 participants will receive either selumetinib or a placebo to see if the drug can shrink the tumors and reduce pa…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control TerminatedThis study tests an oral drug called emavusertib (CA-4948) in adults with acute myeloid leukemia (AML) or a high-risk bone marrow disorder (MDS) that have not responded to or returned after prior treatment. The goal is to find the safest and most effective dose and to see if the …
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Painless eye drops could save sight in kids with brain tumors
Disease control OngoingThis study tests a new painless nerve growth factor eye drop (CHF6467) in 36 children and young adults with optic pathway glioma, a brain tumor that often causes vision loss. The goal is to see if the drops can protect or improve vision without the pain side effects of standard n…
Phase: PHASE2 • Sponsor: Benedetto Falsini • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a common drug slow down this rare brain disease?
Disease control OngoingThis phase 2 trial tests whether glycerol phenylbutyrate (GPB) can slow corticobasal syndrome (CBS), a rare and fast-progressing brain disease. 32 adults with CBS will receive either GPB or a placebo for 26 weeks. The main goal is to see if GPB lowers levels of a nerve damage mar…
Phase: PHASE2 • Sponsor: Technical University of Munich • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can intensive therapy boost motor skills in kids with SMA?
Disease control OngoingThis pilot study tests whether combining intensive hand-arm and leg therapy with strength training can improve motor function in children with spinal muscular atrophy (SMA). Five children will attend one 6-hour session each weekend for 15 weeks. Researchers will check if the ther…
Phase: NA • Sponsor: Teachers College, Columbia University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
GBS drug trial pulled before it even started
Disease control TerminatedThis study aimed to test the safety and effectiveness of efgartigimod in people with Guillain-Barre syndrome (GBS), a rare nerve disorder causing weakness. Participants would have received the drug alongside standard care and undergone blood tests and surveys. However, the trial …
Phase: PHASE2 • Sponsor: Chafic Karam • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug aims to keep rare nerve disease in check long-term
Disease control OngoingThis study is a long-term follow-up for people with multifocal motor neuropathy, a rare condition that causes muscle weakness. It tests the safety and effectiveness of a drug called ARGX-117, given intravenously. The trial includes 51 adults who previously took part in an earlier…
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental combo aims to boost immune attack on sarcoma before surgery
Disease control OngoingThis early-phase study tests the safety of combining two immunotherapy drugs—nivolumab and BO-112—given before surgery for soft tissue sarcoma that can be removed. About 14 adults with certain sarcoma types will receive these drugs to see if they help the immune system fight the …
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for NF1 patients: drug shows promise against inoperable tumors
Disease control OngoingThis study tests a drug called selumetinib in adults with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink these tumors or slow their growth. Participants take the drug twice daily and are monitored …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for rare tumors: drug may slow cancer growth
Disease control OngoingThis study tests a drug called lanreotide in 10 people with advanced or metastatic paraganglioma or pheochromocytoma, rare tumors that release hormones. The goal is to see if lanreotide can slow tumor growth compared to before treatment. Participants receive injections every 4 we…
Phase: PHASE2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Blood pressure drug shows promise in slowing Parkinson's progression
Disease control OngoingThis study looks at whether terazosin, a drug usually used for high blood pressure, can slow the progression of Parkinson's disease. Researchers are tracking changes in heart and brain scans of 15 people who are either in early stages or at high risk for Parkinson's. The goal is …
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for rare tumors? drug axitinib tested in small trial
Disease control OngoingThis phase II trial tests the drug axitinib in 6 adults with metastatic or inoperable pheochromocytoma or paraganglioma, rare tumors of the adrenal glands or nerve tissue. Axitinib works by blocking blood vessel growth that feeds tumors. The main goal is to see how many patients'…
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New surgical technique aims to restore hand pinch after nerve injury
Disease control OngoingThis study tests a surgical procedure that moves two tendons in the forearm to help people with long-term ulnar nerve damage regain the ability to pinch. 17 adults aged 18-60 with stable joints and no other nerve injuries will be followed for 12 weeks after surgery. The goal is t…
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a stem cell transplant stop the immune system from attacking the brain?
Disease control OngoingThis phase 2 trial tests whether high-dose chemotherapy followed by a stem cell transplant can stop the immune system from attacking the nervous system in people with autoimmune neurologic diseases like multiple sclerosis and stiff person syndrome. The treatment aims to weaken th…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Vutrisiran shows promise for Long-Term control of rare heart condition
Disease control ENROLLING_BY_INVITATIONThis study is for people with a rare heart condition called ATTR amyloidosis with cardiomyopathy, where abnormal protein builds up in the heart. It tests the long-term safety and effectiveness of a drug called vutrisiran, given as an injection every three months. About 700 adults…
Phase: PHASE3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Milder stem cell transplant shows promise for kids with immune disorders
Disease control OngoingThis study tests a stem cell transplant using a milder chemotherapy-like regimen to treat children and young adults (up to age 28) with various immune system disorders. The goal is to help the donor stem cells settle in the body with fewer side effects. The study involves 20 part…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a lymphatic bypass surgery soothe diabetic nerve damage?
Disease control ENROLLING_BY_INVITATIONThis study tests a surgery called lymphovenous bypass for people with diabetic peripheral neuropathy, a common complication causing pain, numbness, and foot ulcers. The procedure aims to drain excess lymph fluid, which may reduce inflammation and nerve damage. Researchers will me…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Radioactive drug lutathera tested in teens with rare cancers
Disease control OngoingThis study is testing a radioactive drug called Lutathera in teenagers aged 12 to 17 who have rare tumors of the digestive system or adrenal glands. The goal is to see if the drug is safe and how much radiation reaches organs. Eleven teens are taking part, and researchers are wat…
Phase: PHASE2 • Sponsor: Advanced Accelerator Applications • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug duo aims to ease muscle weakness in myasthenia gravis
Disease control OngoingThis study tests two experimental drugs, pozelimab and cemdisiran, alone or together, in 288 adults with generalized myasthenia gravis (gMG), a disease that causes muscle weakness and fatigue. The goal is to see if the drugs improve daily activities and muscle strength. Participa…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could mild low-oxygen air boost nerve repair without surgery?
Disease control ENROLLING_BY_INVITATIONThis study tests whether breathing short bursts of air with slightly less oxygen can help nerves in the hand heal better after injury. The therapy is non-invasive and aims to improve hand function and reduce pain. About 80 adults with severe carpal tunnel syndrome will be enrolle…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Immune cell therapy aimed at autoimmune diseases hits early snag
Disease control TerminatedThis early-phase trial planned to test a one-time infusion of genetically modified immune cells (CAR-T cells) targeting CD19 in people with several autoimmune diseases, including lupus and multiple sclerosis. The goal was to see if it was safe and could reduce harmful antibodies.…
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Rare cancer hope: immune drug shows promise in phase 2 trial
Disease control OngoingThis study tested a drug called pembrolizumab in 157 people with rare cancers that had spread or couldn't be removed. The drug works by helping the body's immune system attack the cancer. The main goal was to see how many patients were alive and their cancer hadn't grown after 27…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Nerve graft registry tracks recovery in thousands of patients
Disease control OngoingThis study follows over 3,000 people who received the Avance Nerve Graft to repair damaged peripheral nerves. Researchers are tracking safety, sensory and motor function recovery, and quality of life in real-world settings. The goal is to understand how well this processed human …
Sponsor: Axogen Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Virus and radiation combo takes aim at tough sarcomas
Disease control OngoingThis phase 2 trial tests whether injecting a modified herpes virus (TVEC) directly into tumors, combined with radiation therapy before surgery, can shrink advanced soft tissue sarcomas. The study enrolled 2 adults with specific sarcoma types that could not be removed with clear m…
Phase: PHASE2 • Sponsor: John Rieth • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Hope for rare heart disease: new drug aims to slow deadly protein clumps
Disease control OngoingThis study tests a drug called vutrisiran in 655 adults with a rare heart condition caused by abnormal protein buildup (ATTR amyloidosis with cardiomyopathy). The drug is given as a shot every 3 months and aims to reduce deaths and heart-related hospital stays. The goal is to see…
Phase: PHASE3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Mind-Controlled therapy could help restore smiles in facial palsy patients
Disease control ENROLLING_BY_INVITATIONThis study tests whether a non-invasive brain-computer interface combined with mild electrical brain stimulation can improve facial movement in people with peripheral facial palsy. Thirty adults aged 18-70 with moderate to severe facial weakness will receive up to 20 sessions ove…
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New disc implant aims to ease pain after herniated disc surgery
Disease control TerminatedThis study tests a new artificial disc implant (PerQdisc) placed during surgery for a herniated disc. The goal is to see if it is safe and helps reduce back and leg pain. About 50 adults with a single herniated disc in the lower back will take part. The implant is meant to replac…
Phase: NA • Sponsor: Spinal Stabilization Technologies • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New stem cell approach aims to tame rare genetic diseases
Disease control OngoingThis study tests a stem cell transplant method for people with inherited metabolic disorders and severe osteopetrosis. The goal is to get the donor cells to take hold while keeping side effects low. Participants receive chemotherapy drugs before the transplant to prepare their bo…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for nerve disease: batoclimab safety trial expands
Disease control ENROLLING_BY_INVITATIONThis study checks the long-term safety of a drug called batoclimab for adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disorder that causes weakness and numbness. About 108 people who finished an earlier batoclimab study will get weekly injections fo…
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New neck plate aims to stabilize spine after surgery
Disease control ENROLLING_BY_INVITATIONThis study is testing a metal plate (the NuVasive ACP system) used during neck spine surgery to treat conditions like disc disease, stenosis, or fractures. About 75 adults will receive the plate and be followed for up to 24 months to see how safe it is and how well it helps with …
Sponsor: NuVasive • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Robot-Assisted surgery for lung cancer and thymus disease put to the test
Disease control OngoingThis study is testing a new robotic surgery system, the da Vinci SP, for removing part or all of a lung (lobectomy) or the thymus gland (thymectomy) in people with lung cancer, benign lung disease, thymoma, or myasthenia gravis. The goal is to see if the robot can perform these s…
Phase: NA • Sponsor: Intuitive Surgical • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Common painkiller tested against rare brain tumors
Disease control OngoingThis phase II trial tests whether aspirin can delay tumor growth and maintain hearing in people with vestibular schwannoma (acoustic neuroma), a non-cancerous brain tumor. About 97 participants are randomly assigned to take aspirin or a placebo twice daily. The study tracks how l…
Phase: PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New device may save hearing options after brain tumor removal
Disease control TerminatedThis study was designed to see if a small device placed in the inner ear during acoustic neuroma surgery can keep the cochlea from filling with scar tissue. If successful, patients who lose hearing from the surgery could still get a cochlear implant later. The study was withdrawn…
Phase: NA • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New pill takes on Hard-to-Treat cancers in first human trial
Disease control OngoingThis early-stage trial tests an experimental oral drug called PRJ1-3024 in 39 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the right dose. Researchers will also look for early signs that the drug may s…
Phase: PHASE1 • Sponsor: Zhuhai Yufan Biotechnologies Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Korean herbs and spinal manipulation show promise for disc pain
Disease control OngoingThis observational study is testing whether integrative Korean medicine—combining herbal medicine and Chuna manual therapy—can safely reduce pain and improve quality of life in 120 adults with cervical disc herniation and radiculopathy. Participants receive treatment at four Kore…
Sponsor: Jaseng Medical Foundation • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New combo therapy targets nerve pain in rare blood cancers
Disease control OngoingThis study tests whether combining acalabrutinib with rituximab is safe and effective for people with nerve damage (neuropathy) linked to two blood conditions: IgM MGUS or Waldenstrom macroglobulinemia. The main goal is to see if the treatment lowers a key protein (IgM) in the bl…
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a porcine nerve wrap save shoulder function after cancer surgery?
Disease control TerminatedThis study tests whether wrapping the spinal accessory nerve with a porcine (pig) tissue product during neck dissection for head and neck cancer can prevent shoulder problems. About 74 adults who have not had prior neck surgery will be enrolled. Researchers will measure shoulder …
Phase: NA • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug shows promise for Long-Term control of rare nerve disease
Disease control OngoingThis study looks at the long-term safety and effects of a drug called eplontersen in people with a rare inherited nerve disease called hATTR-PN. About 151 participants who completed earlier studies will receive regular injections of eplontersen. The goal is to see if the drug rem…
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
SPINRAZA study tracks movement in adults with spinal muscular atrophy
Disease control OngoingThis study follows 20 adults with spinal muscular atrophy (SMA) type II who are already taking SPINRAZA. Researchers will measure motor function using a 32-point scale over 27 months to see if the drug helps maintain or improve movement. The goal is to better understand how SPINR…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Gene therapy aimed at cutting opioid use for diabetic nerve pain – but trial never started
Disease control TerminatedThis study planned to test a gene therapy called VM202 in people with painful diabetic neuropathy who were already taking opioid painkillers. The goal was to see if VM202 could help them safely reduce their opioid dose. However, the trial was withdrawn before any participants wer…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Gene therapy boost for krabbe patients after transplant
Disease control OngoingThis early-phase trial tests a single infusion of a gene therapy called FBX-101 in 9 people with Krabbe disease who have already received a stem cell transplant. The therapy uses a harmless virus to deliver a working copy of the GALC gene, aiming to improve motor function and saf…
Phase: PHASE1, PHASE2 • Sponsor: Forge Biologics, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Engineered immune cells take on childhood cancers in first human test
Disease control OngoingThis early-stage trial tests a new type of immunotherapy for children and young adults with solid tumors that have not responded to standard treatments. The therapy uses the patient's own immune cells (T cells) that are genetically modified to recognize and attack cancer cells ca…
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Gene therapy hope for babies with fatal muscle disease
Disease control OngoingThis study tests a new gene therapy called SKG0201 in 12 infants with spinal muscular atrophy type 1, a severe muscle-weakening disease. The treatment aims to improve survival and motor skills by delivering a working gene. Researchers are checking safety and how well the therapy …
Phase: NA • Sponsor: Kun Sun • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
MS patients switch meds: will a cheaper option work just as well?
Disease control OngoingThis study looks at people with relapsing-remitting multiple sclerosis who switched from the drug MabThera to a similar, lower-cost medicine called Rixathon. Researchers want to see if the switch changes signs of nerve damage, new brain lesions, relapses, or disability. They will…
Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug cocktail shows promise for rare cancers
Disease control OngoingThis phase 2 trial is testing whether a combination of two drugs, talazoparib and temozolomide, can shrink tumors in people with rare cancers that have spread. The study includes 14 participants with advanced rare solid tumors, such as pheochromocytoma or paraganglioma, who have …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for tough chest tumors: targeted radiation trial launches
Disease control ENROLLING_BY_INVITATIONThis study tests a new type of radiation therapy called BNCT for people with chest tumors that have come back and cannot be removed by surgery or treated with standard methods. About 30 participants will receive a special boron drug followed by neutron radiation to target cancer …
Phase: PHASE1, PHASE2 • Sponsor: Stella Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a common mineral slow Parkinson's? new trial begins
Disease control ENROLLING_BY_INVITATIONThis study is testing whether low-dose lithium aspartate, a dietary supplement, can slow the progression of Parkinson's disease. It involves 35 people who have already completed a lithium trial, and they will take lithium for another 24 weeks. Researchers will use brain scans and…
Phase: PHASE1, PHASE2 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
One-Person trial aims to treat rare nerve disorder with custom drug
Disease control ENROLLING_BY_INVITATIONThis study tests a custom-made drug called an antisense oligonucleotide (ASO) designed for one person with Charcot-Marie-Tooth disease type 2D (CMT2D) caused by a specific GARS1 gene mutation. The drug aims to improve motor skills and quality of life. Only one participant is enro…
Phase: PHASE1, PHASE2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Hope for rare Muscle-Weakening disease: new drug trial targets Antibody-Negative patients
Disease control OngoingThis study tests an investigational drug called efgartigimod, given intravenously, for adults with generalized myasthenia gravis (gMG) who do not have the typical acetylcholine receptor antibodies. The trial compares the drug to a placebo to see if it improves daily activities an…
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
One-Patient trial hopes to fix rare nerve disease at its genetic root
Disease control OngoingThis study tests a custom-made drug (VCA-894A) in a single person with a rare genetic nerve disease called CMT2S. The drug is designed to correct a specific genetic error and restore a missing protein. The main goals are to check if the treatment is safe and if it can improve mus…
Phase: PHASE1, PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New device aims to strengthen neck fusion surgery
Disease control OngoingThis study tests a device called PCSS used alongside standard neck fusion surgery to treat degenerative disc disease in the neck. About 236 adults aged 18-80 who need surgery on three neck levels will be enrolled. The goal is to see if the device helps bones fuse better and safel…
Phase: NA • Sponsor: Providence Medical Technology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Gene therapy for rare brain diseases: 5-Year safety check begins
Disease control OngoingThis study follows 7 people who previously received a gene therapy called AXO-AAV-GM2 for Tay-Sachs or Sandhoff disease — rare, fatal genetic disorders that destroy nerve cells. Researchers will track them for up to 5 years to see if the treatment remains safe and whether it help…
Sponsor: Terence Flotte • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New pill aims to slow rare brain disease in landmark trial
Disease control OngoingThis Phase 2 trial tests an oral drug called FNP-223 in 241 people with progressive supranuclear palsy (PSP), a rare brain disorder that causes problems with balance, eye movement, and thinking. The study compares the drug to a placebo over 52 weeks to see if it can slow the dise…
Phase: PHASE2 • Sponsor: Ferrer Internacional S.A. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Promising nerve pain drug trial for MGUS patients withdrawn before start
Disease control TerminatedThis study aimed to test if daratumumab could improve nerve damage (peripheral neuropathy) in people with a blood condition called MGUS. Participants would have received weekly injections for two months, then biweekly for four more months. However, the trial was withdrawn before …
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
One-Time gene injection aims to halt rare childhood paralysis
Disease control ENROLLING_BY_INVITATIONThis early-stage trial tests a single injection of gene therapy for people with SMARD1 or CMT2S, rare diseases caused by mutations in the IGHMBP2 gene. The therapy delivers a working copy of the gene directly into the spinal fluid. Ten participants, ranging from infants to childr…
Phase: PHASE1, PHASE2 • Sponsor: Megan Waldrop • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New proton beam therapy aims to save hearing in brain tumor patients
Disease control OngoingThis study tests a precise type of radiation called proton therapy for people with a non-cancerous brain tumor called vestibular schwannoma. The goal is to see if this treatment can preserve hearing and control tumor growth while reducing side effects. About 30 adults with useful…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
One Patient's last hope: stem cells for rare nerve disease
Disease control NO_LONGER_AVAILABLEThis study gives one patient with CIDP access to their own stored stem cells to see if it's safe and might help. The patient receives multiple infusions over 44 weeks and is followed for a year. Because it's only one person, the results are very limited.
Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug targets genetic weakness in Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called pacritinib in people with advanced solid tumors (like breast cancer) that have a specific genetic change called 1q21.3 amplification. The goal is to see if the drug can shrink tumors or slow their growth. About 74 adults whose cancer has not respond…
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New combo shows promise for tough kidney cancers
Disease control OngoingThis study tests two drugs, nivolumab and cabozantinib, together in 60 people with advanced or metastatic non-clear cell kidney cancer. The goal is to see how well the combination shrinks tumors. Participants take cabozantinib daily and receive nivolumab infusions every two weeks…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a cancer drug help CIDP patients ditch their meds?
Disease control TerminatedThis study planned to test the drug rituximab in people with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve condition that causes weakness and numbness. The goal was to see if rituximab could help certain patients stop their current treatments and achieve long-…
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 26, 2026 18:31 UTC
-
Could a short pill course save hand function in advanced MS?
Disease control OngoingThis UK trial tests whether cladribine tablets, taken for just 8-10 days a year over two years, can slow the loss of hand function in people with advanced multiple sclerosis (MS). The study includes 204 participants with significant disability (EDSS 6.5-8.5). Half receive cladrib…
Phase: PHASE2, PHASE3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 26, 2026 15:20 UTC
-
Gene therapy hope for rare brain disease in children
Disease control OngoingThis study tests a single infusion of OTL-200 gene therapy in 6 people with late juvenile metachromatic leukodystrophy (MLD), a rare genetic disease that damages the brain and nerves. The therapy uses the patient's own blood stem cells, modified to produce a missing enzyme. Resea…
Phase: PHASE3 • Sponsor: Orchard Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 13:33 UTC
-
Could a tiny jolt to the head diagnose balance problems?
Diagnosis ENROLLING_BY_INVITATIONThis early study will test whether weak electrical currents applied to the head can help diagnose balance disorders like vestibular schwannoma and vestibular neuritis. Researchers will measure how 30 people with these conditions sway or move in response to the stimulation. The go…
Phase: NA • Sponsor: Aalto University • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
AI reads brain scans to spot Parkinson's lookalikes
Diagnosis OngoingThis study tests an AI tool called AIDP that analyzes MRI scans to help diagnose Parkinson's disease and two similar conditions (MSA and PSP). Researchers at 21 sites will compare the AI's diagnosis to that of movement disorder specialists. The goal is to see if the tool can impr…
Sponsor: University of Florida • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
New scan could spot hidden tumors more accurately
Diagnosis OngoingThis study tests whether a new type of PET/CT scan, using a radioactive tracer called 68Ga-DOTATOC, can find neuroendocrine tumors (NETs) and similar tumors more safely and accurately than current imaging methods. About 800 people with known or suspected NETs will receive the sca…
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
New scan may improve detection of childhood nerve tumors
Diagnosis OngoingThis study involves 20 children and young adults with neuroendocrine tumors (like neuroblastoma) that have spread. Researchers are testing whether a special PET/CT scan using a radioactive tracer called 68Ga-DOTATATE can find tumors better than the standard MIBG scan. The goal is…
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Needle-Free carpal tunnel diagnosis on the horizon?
Diagnosis ENROLLING_BY_INVITATIONThis study explores whether ultrasound elastography, a non-invasive imaging technique, can accurately diagnose carpal tunnel syndrome (CTS) without the need for painful needle-based nerve tests. Researchers will enroll 80 participants—some with CTS and some healthy volunteers—to …
Sponsor: Da Nang Family General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:04 UTC
-
Brain scan breakthrough could save babies from rare disease
Diagnosis OngoingThis study looks at whether a special brain scan called diffusion tensor imaging (DTI) can help doctors find Krabbe disease in newborns and decide who needs urgent treatment. About 100 babies with a positive newborn screen or family history of Krabbe disease will be scanned and f…
Sponsor: University of Pittsburgh • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Simple blood test could catch hidden heart disease in seniors
Diagnosis ENROLLING_BY_INVITATIONThis study is testing a way to find cardiac amyloidosis—a rare but serious heart condition—earlier in people aged 65 and older. Researchers in Turkey will screen 800 patients at family medicine clinics using simple blood tests and medical history. The goal is to see if this appro…
Sponsor: Kotyora Family Medicine Health Management and Education Association • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Quick Needle-Free test could spot long COVID
Diagnosis ENROLLING_BY_INVITATIONThis study tests a new, non-invasive diagnostic method for long COVID. Researchers will use a single-session bioelectrical assessment to detect patterns linked to viral persistence in 50 adults with long COVID. The goal is to see if this approach can reliably identify ongoing vir…
Phase: NA • Sponsor: Oncology Center,Ministry Of Heath,Uzbekistan • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Can Full-Body scans spot cancer early in High-Risk families?
Diagnosis OngoingThis study is testing whether whole body MRI scans can help find cancers early in children and adults with Li-Fraumeni syndrome, a genetic condition that greatly raises cancer risk. About 150 participants will receive annual whole body MRI scans for four years to see if they keep…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Which scan spots hidden tumors best? new study aims to find out
Diagnosis OngoingThis study compares three different PET/CT scans (68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG) in 50 people with metastatic neuroendocrine tumors. The goal is to see if all tumors show up on the standard scan or if some are missed, which could change treatment. Participants will get …
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Algorithm aims to spot rare heart disease in medical records
Diagnosis TerminatedThis study aimed to test a computer algorithm that uses insurance claims data to identify people with ATTR amyloidosis, a rare disease that affects the heart and nerves. Researchers planned to check how well the algorithm worked by reviewing medical records. However, the study wa…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Diagnosis
Last updated Jun 26, 2026 18:38 UTC
-
New test could predict falls in muscle disease patients
Diagnosis ENROLLING_BY_INVITATIONThis study aims to create a simple test battery to determine fall risk in people with neuromuscular disorders, such as muscular dystrophy or ALS. Researchers will assess 108 participants using several physical tests like walking, standing, and rising from a chair. The goal is to …
Sponsor: LMU Klinikum • Aim: Diagnosis
Last updated Jun 26, 2026 16:30 UTC
-
New york program offers extra screening for 100,000 newborns
Diagnosis ENROLLING_BY_INVITATIONScreenPlus is a large pilot program that offers families the option to have their newborn screened for a panel of rare genetic disorders, in addition to standard newborn screening. The study aims to screen 100,000 infants born at eight hospitals in New York. Researchers will eval…
Sponsor: Albert Einstein College of Medicine • Aim: Diagnosis
Last updated Jun 26, 2026 16:15 UTC
-
New screening tool aims to catch diabetic nerve damage early
Diagnosis OngoingThis study tests a short questionnaire called ACT to see if it can accurately detect nerve damage in the feet and legs of people with diabetes. Researchers will compare it to standard screening tools and an eye test that looks at tiny nerve fibers. The goal is to find a simple, n…
Sponsor: Weill Cornell Medical College in Qatar • Aim: Diagnosis
Last updated Jun 26, 2026 14:24 UTC
-
Wearable insoles warn of foot pressure to stop diabetic ulcers
Prevention OngoingThis trial tests a wearable insole system that monitors foot pressure, temperature, and movement, giving real-time alerts to help users shift weight and avoid injury. The study includes people with type 1 or 2 diabetes who have nerve damage and a recent history of healed foot ulc…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
New pill aims to stop chemo from stealing hearing
Prevention TerminatedThis study was designed to test whether an oral drug called SPI-1005 could prevent hearing loss and ringing in the ears caused by platinum-based chemotherapy. It was planned for adults with advanced lung or head and neck cancer. The study was withdrawn before enrolling any partic…
Phase: PHASE2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
New hope: natural compound may stop chemo nerve pain
Prevention TerminatedThis study tests a natural substance called GM1 to see if it can prevent nerve damage (pain, numbness, tingling) caused by the chemotherapy drug paclitaxel in people with metastatic breast cancer. About 98 participants will receive either GM1 or a placebo alongside their chemo. T…
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Can a common drug stop Chemo's nerve pain?
Prevention TerminatedThis phase II trial tests whether riluzole, a drug used for ALS, can prevent nerve damage caused by oxaliplatin chemotherapy in people with stage II/III colorectal cancer. About 80 participants will receive either riluzole or a placebo during their chemo. The study is currently s…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Cold hands, healthy nerves? study tests cryotherapy to block chemo side effect
Prevention TerminatedThis study tests whether wearing cold gloves during chemotherapy can prevent peripheral neuropathy (nerve damage causing numbness, tingling, or pain) in colon cancer patients. Forty adults with stage III colon cancer who are about to start a common chemo regimen (CAPOX) will be r…
Phase: NA • Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
Simple glove trick may shield breast cancer patients from chemo nerve pain
Prevention OngoingThis study tests whether wearing two layers of surgical gloves during paclitaxel chemotherapy can prevent nerve damage in the hands. About 104 breast cancer patients will be randomly assigned to wear the gloves or not. Researchers will compare changes in nerve pain and function b…
Phase: NA • Sponsor: Young-Joon Kang • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Common antidepressant may shield cancer patients from chemo nerve damage
Prevention OngoingThis phase II/III trial tests whether duloxetine, a drug used for depression and pain, can prevent the nerve damage (pain, tingling, numbness) caused by oxaliplatin chemotherapy in stage II-III colorectal cancer patients. About 220 participants will receive either duloxetine or a…
Phase: PHASE2, PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Jun 27, 2026 08:14 UTC
-
Cookie cure? golden rice snack may prevent diabetic nerve damage
Prevention OngoingThis study tests whether cookies made from golden rice and red betel leaf can help prevent diabetic neuropathy, a common nerve damage complication of diabetes. 102 adults with diabetes will eat one cookie daily for 28 days. Researchers will measure changes in nerve symptoms and b…
Phase: NA • Sponsor: Hasanuddin University • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Elastic band exercises may stop diabetic foot ulcers before they start
Prevention OngoingThis study looks at whether foot and ankle exercises using elastic bands can help prevent diabetic foot ulcers in people with diabetic neuropathy. About 80 participants with type 2 diabetes and nerve damage in their feet will do these exercises. Researchers will track how many ul…
Phase: NA • Sponsor: St Elisabeth School Health Science • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Tiny implant zaps nerve pain: new study tests relief without drugs
Symptom relief OngoingThis study tests a small implanted device that sends mild electrical pulses to nerves to relieve chronic pain from injury or surgery. About 89 adults with long-lasting pain in the back, shoulder, knee, or foot will either get the implant plus usual care or usual care alone. The g…
Phase: NA • Sponsor: Nalu Medical, Inc. • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Shocking nerve pain away: new device trial for diabetic neuropathy
Symptom relief OngoingThis study tests whether a device that sends mild electrical pulses to the spinal cord (10 kHz SCS) can reduce pain and improve nerve function in people with painful diabetic neuropathy. About 143 participants will either get standard medical care alone or the device plus standar…
Phase: NA • Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Zapping the brain to quiet diabetic nerve pain
Symptom relief OngoingThis study tests whether two non-invasive brain stimulation techniques—transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound (TUS)—can reduce chronic pain in people with diabetic neuropathy. Participants, aged 40 to 80 with foot pain lasting at least 6 months…
Phase: NA • Sponsor: Case Western Reserve University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can yoga ease severe headaches? small pilot study aims to find out
Symptom relief OngoingThis pilot study is testing whether yoga-based movements, done online or in person, can help people with chronic migraine or cluster headache. Twenty adults aged 18-65 will participate. The goal is to see if yoga improves headache frequency, sleep quality, and overall well-being …
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Spinal implant offers new hope for diabetic leg pain
Symptom relief OngoingThis study looks at how well a spinal cord stimulator works in real-world settings for people with long-term leg pain caused by diabetic neuropathy. About 500 participants will receive the implant and be followed for a year. Researchers will measure pain relief, quality of life, …
Phase: NA • Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Brain training plus drug may ease chemo nerve damage
Symptom relief OngoingThis phase 2 trial tests whether combining neurofeedback (a brain-wave training therapy) with the drug duloxetine can better relieve nerve pain caused by chemotherapy than either treatment alone. About 336 cancer survivors with persistent nerve pain will be randomly assigned to o…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Laser light may soothe diabetic nerve pain
Symptom relief OngoingThis study tests a non-invasive light therapy called photobiomodulation (low-level laser) for people with diabetic peripheral neuropathy—nerve damage causing pain, tingling, and numbness in the feet. 36 adults with type 2 diabetes and foot pain for at least 6 months will receive …
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New device combo aims to quiet jaw pain without drugs
Symptom relief OngoingThis study tests whether two devices, used one after the other, can reduce pain and disability from temporomandibular joint (TMJ) disorders. Adults aged 22 and older with TMJ pain will receive four treatment sessions and be followed for three months. Researchers will measure chan…
Phase: NA • Sponsor: BTL Industries Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Laser light shows promise for rare nerve pain
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether photobiomodulation (low-level laser therapy) can reduce pain and disability in people with anti-MAG neuropathy, a rare nerve condition. Ten participants will receive 16 laser sessions over six weeks. Researchers will measure changes in disability, pain, a…
Sponsor: Centre Hospitalier de Cornouaille • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Hemp compound tested for spinal cord injury pain relief
Symptom relief OngoingThis small early-phase trial tests whether a single oral dose of a hemp-derived CBD/CBD-A extract can reduce neuropathic pain and change brain activity in people with spinal cord injury. Six participants with moderate to severe nerve pain for at least three months will receive ei…
Phase: PHASE1, PHASE2 • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Freezing nerves could offer new hope for diabetic foot pain
Symptom relief OngoingThis study tests a procedure called cryoneurolysis, which uses a small probe to freeze nerves in the foot and block pain signals. It is for adults with painful diabetic neuropathy who have at least moderate pain daily. Thirty participants will be randomly assigned to receive eith…
Phase: NA • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Custom 3D printed insoles may help diabetic patients avoid foot ulcers
Symptom relief OngoingThis study tests whether 3D printed custom insoles are better than regular ready-to-wear insoles at reducing foot pressure in people with diabetic neuropathy. High foot pressure can lead to ulcers and mobility problems. Twenty-two adults with diabetes and nerve damage will be ran…
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple foot massage ease chemo nerve pain?
Symptom relief OngoingThis study investigates whether foot massage using a roller can reduce nerve pain caused by chemotherapy in cancer patients. About 80 adults receiving certain chemotherapy drugs will either receive foot massage twice daily for three weeks or continue with routine care. The goal i…
Phase: NA • Sponsor: Ataturk University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Nerve zapper offers hope for chronic headache sufferers
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether a 60-day nerve stimulation device placed near the back of the head can help people with stubborn headaches. Researchers will track pain levels, daily function, and how often participants need emergency care. About 300 adults with various headache types…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Sniff your way back: daily scent training may restore lost smell
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether daily exposure to different scents can retrain the sense of smell in 250 adults with smell disorders, including those from traumatic brain injury. Participants will use scented inhaler sticks at home and take smell tests before and after 12 weeks. The goa…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Vibrating leg device tested to improve walking in young cancer survivors
Symptom relief OngoingThis pilot study tests whether a vibrating device strapped to the leg can improve walking in young cancer survivors (ages 6-39) who have nerve damage from chemotherapy. Ten participants will have the device applied to leg muscles while their step times are measured. The goal is t…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Which therapy works better for sciatica? small trial pits mobilization against traction
Symptom relief OngoingThis study compares two physical therapy methods for people with lumbar radiculopathy (a pinched nerve in the lower back causing leg pain). Thirty adults aged 25 to 50 with moderate disability will receive either spinal mobilization with leg movement or mechanical traction for fo…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Ultrasound-Delivered pain gel shows promise for carpal tunnel sufferers
Symptom relief OngoingThis study tests whether a pain-relief gel (pregabalin) delivered through the skin using ultrasound can reduce pain and improve hand function in people with carpal tunnel syndrome. The treatment is given four times a week for a month, and compared to standard ultrasound therapy w…
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Could botox stop nerve pain before it becomes chronic?
Symptom relief TerminatedThis study tests whether giving Botox injections early can reduce nerve pain that occurs after chest surgery (thoracoscopy or thoracotomy). Participants have had daily nerve pain for three months. The trial compares Botox to a placebo to see if it lowers pain intensity and preven…
Phase: PHASE3 • Sponsor: University Hospital, Limoges • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Neck pain study tests belt vs. fisted traction
Symptom relief OngoingThis study compares two manual traction techniques—Mulligan belt traction and fisted traction—for people with lower cervical radiculopathy (pinched nerve in the neck causing pain down the arm). 44 adults aged 25-60 with moderate pain will be assigned to one of the two methods. Re…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New stretching combo may ease sciatica pain
Symptom relief OngoingThis study tests two physical therapy techniques for people with lumbar radiculopathy (sciatica). One group does a standard muscle stretching method, while the other adds a nerve-gliding exercise. Researchers will measure pain, flexibility, and daily function in 22 adults aged 30…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Exercise program aims to ease chemo nerve damage in cancer survivors
Symptom relief OngoingThis study tests whether a 10-week, at-home exercise program is safe and helpful for cancer survivors who have ongoing nerve pain, numbness, or tingling from chemotherapy. About 40 participants will do remote exercise sessions and health coaching calls. The goal is to see if the …
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Can special exercises help diabetics avoid falls?
Symptom relief OngoingThis study tests two different exercise programs in 40 people with diabetic peripheral neuropathy, a condition that causes numbness and balance problems. One program uses Feldenkrais exercises, which focus on movement awareness, and the other uses task-oriented gait training, whi…
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Nerve cap aims to ease pain after limb loss
Symptom relief OngoingThis study tests a special nerve cap (Axoguard Large-Diameter Nerve Cap) in 15 adults who have had a limb injury or amputation. The cap is placed over the cut nerve end to protect it and may help reduce chronic nerve pain. The goal is to see if the cap is safe and works well befo…
Phase: NA • Sponsor: Axogen Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New hope for chemo pain: nerve zap study launches
Symptom relief OngoingThis study tests a treatment called neuromodulation to see if it can reduce nerve pain caused by chemotherapy. About 24 adults with nerve pain in their legs from certain chemo drugs will take part. Researchers will check for side effects and measure changes in pain and nerve func…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Scrambler therapy offers hope for young cancer survivors with nerve pain
Symptom relief OngoingThis study looks at whether Scrambler therapy can safely reduce painful nerve damage caused by chemotherapy in adolescents and young adults (ages 15-39) who have finished active cancer treatment. Participants are randomly assigned to receive the therapy right away or after a wait…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Spinal zap trial aims to calm chemo nerve pain
Symptom relief TerminatedThis small pilot study tests whether a closed loop spinal cord stimulator can reduce pain and improve quality of life for people with nerve damage from chemotherapy. Ten adults with chemotherapy-induced peripheral neuropathy in their legs will receive the device and be monitored …
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New pill could ease diabetic nerve pain for good
Symptom relief OngoingThis study tests a drug called suzetrigine (VX-548) for long-term safety and pain relief in people with diabetic peripheral neuropathy. About 455 adults who completed a prior 12-week study will take the drug for up to one year. Researchers will track side effects and changes in p…
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New hope for back pain sufferers: no surgery needed?
Symptom relief OngoingThis study looks at whether a non-surgical treatment called spinal decompression can help people with chronic low back pain. About 42 adults with back pain from disc problems or sciatica will receive the treatment over 12 weeks. Researchers will use MRI scans and movement tests t…
Phase: NA • Sponsor: University of South Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could a daily 5-Minute mask soothe nerve pain?
Symptom relief OngoingThis phase 2 trial tests a special hand and foot mask designed to ease nerve pain caused by chemotherapy or diabetes. Sixty adults will apply the mask daily for 5 minutes over one week. Researchers will measure changes in symptoms and quality of life using questionnaires.
Phase: PHASE2 • Sponsor: SHIANG-SUO HUANG • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Vitamin d may ease Chemo's nerve pain
Symptom relief TerminatedThis study looks at whether taking vitamin D can reduce nerve pain caused by chemotherapy in people with low vitamin D levels. About 120 cancer patients will be split into two groups: one gets vitamin D supplements, the other gets standard care. The goal is to see if vitamin D he…
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New device aims to zap diabetic nerve pain
Symptom relief ENROLLING_BY_INVITATIONThis study tests a spinal cord stimulator (BurstDR) to relieve chronic pain from diabetic neuropathy. Twenty adults with long-lasting leg pain will try a temporary device for one week. If their pain drops by at least half, they can get a permanent implant. The study tracks pain l…
Phase: NA • Sponsor: TriCity Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New nerve patch could ease pain after biopsy
Symptom relief OngoingThis study tests a biodegradable tube that is placed over a cut nerve during a leg biopsy. The goal is to see if it is safe and reduces common side effects like pain, redness, and swelling. Twenty adults with various nerve conditions are taking part, and half will get the tube wh…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Robot walks could ease nerve pain in spinal injury patients
Symptom relief OngoingThis study tests whether walking with a robotic exoskeleton three times a week for 12 weeks can reduce nerve pain in people with spinal cord injury. Forty adults with traumatic spinal injury and persistent nerve pain will be randomly assigned to either robotic walking or a relaxa…
Phase: NA • Sponsor: University College Dublin • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can squeezing hands and feet stop chemo nerve pain?
Symptom relief OngoingThis study tests whether wearing pressurized gloves and foot caps during chemotherapy can prevent nerve damage (peripheral neuropathy) caused by the drug paclitaxel. It involves 182 people with nasopharyngeal cancer who have not yet started treatment. Each patient serves as their…
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Scientists pinpoint ideal painkiller dose for diabetic foot operations
Symptom relief OngoingThis study aims to find the smallest effective dose of the numbing drug ropivacaine for blocking leg nerves during diabetic foot surgery. Researchers will test different concentrations in 45 adults to see which dose works best for 90% of patients. The goal is to provide effective…
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New study aims to find best anesthesia for back surgery recovery
Symptom relief ENROLLING_BY_INVITATIONThis study looks at two ways to numb people for lower back surgery: general anesthesia (being fully asleep) plus a nerve block, or spinal anesthesia (numbing only the lower body) plus a nerve block. The goal is to see which approach helps patients recover better and feel less pai…
Phase: PHASE3 • Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New drug aims to ease chronic nerve pain from polyneuropathy
Symptom relief OngoingThis study tests a new drug called LY3848575 for people with long-term nerve pain starting in the feet and moving up the legs. About 558 participants will receive either the drug or a placebo to see if it safely reduces pain. The trial lasts up to 30 weeks and measures pain inten…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Ketamine infusion may ease chronic nerve pain in brachial plexus injuries
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether giving ketamine during and after surgery can reduce chronic nerve pain in people with traumatic brachial plexus injuries. About 100 adults will receive a ketamine infusion during their reconstructive surgery and for 24 hours afterward. Researchers will me…
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Exercise may soothe chemo nerve pain, trial hopes
Symptom relief OngoingThis study tests whether a structured exercise program can reduce chemotherapy-induced peripheral neuropathy (CIPN) — nerve damage causing pain, numbness, or tingling. About 133 cancer patients who received certain chemotherapies will either follow an exercise plan or receive sta…
Phase: NA • Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a Hands-On therapy help diabetic nerve pain and blood sugar?
Symptom relief OngoingThis pilot study tested whether two types of manual therapy (nerve mobilization and neck-based techniques) could help control blood sugar and reduce pain in 75 adults with diabetic peripheral neuropathy. Participants received twice-weekly sessions for 12 weeks, and the study focu…
Phase: NA • Sponsor: Abeer Abdrabo • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Back pain breakthrough? study compares two needle treatments for lasting relief
Symptom relief OngoingThis study compares two common procedures for chronic back pain caused by a slipped disc or narrowed spine: a steroid injection and a nerve-targeting radiofrequency treatment. Researchers will track pain levels in 200 adults right after the procedure and three weeks later. The go…
Sponsor: Marmara University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Electric zaps to the head may ease cluster headaches
Symptom relief OngoingThis early study tests the safety of a new device called PRIMUS that uses mild electrical pulses on nerves in the forehead and back of the head to treat chronic cluster headache. Five people with frequent, hard-to-treat attacks will be enrolled. The goal is to see if the device i…
Phase: NA • Sponsor: Salvia BioElectronics • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a 12-Week online course help babies with SMA develop better?
Symptom relief OngoingThis study tests a 12-week online program for mothers of infants (12-36 months old) with SMA Type 1. The program aims to teach mothers how to support their baby's development and improve their own knowledge. Thirteen mothers will take part, with 10 receiving the program and 3 rec…
Phase: NA • Sponsor: Medipol University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Fat-Dissolving drug may shrink NF1 skin tumors
Symptom relief ENROLLING_BY_INVITATIONThis early-stage trial tests whether monthly injections of Kybella (a drug that dissolves fat) can safely shrink skin tumors in people with Neurofibromatosis Type 1. Up to 15 adults will receive up to 6 monthly treatments, and researchers will compare treated and untreated tumors…
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a capsaicin patch ease diabetic foot pain? new study investigates
Symptom relief OngoingThis study is testing whether repeated use of QUTENZA (a capsaicin 8% patch) can reduce pain and the need for painkillers in adults with painful diabetic nerve damage in the feet. About 144 participants will receive up to three patch applications, each 12 weeks apart. Researchers…
Sponsor: Averitas Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a simple muscle zap boost pain relief for back pain sufferers?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether adding a daily 30-minute muscle stimulation session can improve pain control and quality of life for people who already have a spinal cord stimulator (BurstDR) for chronic back pain. Sixty adults with failed back surgery syndrome or persistent spinal p…
Phase: NA • Sponsor: Jessa Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Can learning about pain or using tape ease carpal tunnel symptoms?
Symptom relief OngoingThis study tests two simple treatments for mild to moderate carpal tunnel syndrome: pain neuroscience education (learning how the brain processes pain) and kinesio taping (applying elastic tape to the wrist). Sixty adults aged 18 to 60 with symptoms for at least 3 months will rec…
Phase: NA • Sponsor: Middle East University • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Can remote rehab beat home workouts for piriformis pain?
Symptom relief ENROLLING_BY_INVITATIONThis study compares two exercise programs—asynchronous telerehabilitation (remote guidance) and a standard home exercise plan—for people with piriformis syndrome, a condition causing buttock and leg pain. About 46 adults aged 18-45 with confirmed diagnosis will participate. The g…
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Sugar water injection may ease carpal tunnel pain
Symptom relief OngoingThis study tests whether injecting a 5% dextrose (sugar water) solution around the nerve in the wrist can reduce pain and improve hand function in people with mild to moderate carpal tunnel syndrome. About 96 adults who haven't gotten better with standard care will receive the in…
Phase: NA • Sponsor: Antalya Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New dissolving film may stop dangerous episodes in rare nerve disease
Symptom relief ENROLLING_BY_INVITATIONThis study tests a medicated film placed under the tongue to quickly ease severe episodes (autonomic crises) in people with familial dysautonomia. The film contains dexmedetomidine, a drug that calms the body's stress response. Researchers will check if it reduces symptoms like h…
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New online program aims to ease chronic facial pain without drugs
Symptom relief OngoingThis study tests a self-guided web program called Face-Forward-Web for adults with chronic orofacial pain (lasting over 3 months). The program includes five 30-minute video sessions teaching relaxation, mindfulness, and coping skills. Researchers will enroll up to 30 participants…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New hope for rare burning pain: drug trial targets genetic cause
Symptom relief ENROLLING_BY_INVITATIONThis early-stage study tests whether BHV-7000 can reduce chronic pain in people with inherited erythromelalgia, a rare condition causing severe burning pain due to a genetic mutation. Only 5 adults with a specific NaV1.7 mutation will participate, comparing the drug to a placebo …
Phase: PHASE1 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Could a common constipation drug help diabetics?
Symptom relief OngoingThis study tests whether linaclotide (Linzess) can improve bowel movement frequency in people with type 2 diabetes who have chronic constipation. About 23 participants will receive either the drug or a placebo for two weeks, then switch after a break. The goal is to see if the dr…
Phase: PHASE4 • Sponsor: Texas Tech University Health Sciences Center, El Paso • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Could a simple tourniquet change cut Post-Surgery pain and opioid use?
Symptom relief OngoingThis study tests whether using a lower-pressure tourniquet during orthopedic surgeries can reduce pain and the need for opioid painkillers afterward. Standard tourniquets use high pressure, which can cause muscle weakness and pain. The experimental device sets pressure based on t…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
New pain drug mirogabalin tested in Real-World diabetes study
Symptom relief OngoingThis study is tracking over 700 Chinese adults with diabetic peripheral neuropathic pain who are starting mirogabalin. Researchers are monitoring side effects and how well the drug works in everyday medical practice. The goal is to see if mirogabalin is a safe and effective optio…
Sponsor: Daiichi Sankyo • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Mud vs. wax: which soothes carpal tunnel pain best?
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether warm paraffin wax baths or mud therapy (peloidotherapy) can reduce pain and improve hand function in people with mild to moderate carpal tunnel syndrome. Ninety adults will be split into three groups: one gets mud plus home exercises, another gets wax plu…
Phase: NA • Sponsor: Konya Beyhekim Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Carpal tunnel showdown: shots or knife?
Symptom relief OngoingThis study looks at two treatment plans for carpal tunnel syndrome, which causes hand numbness and pain. One plan starts with up to two steroid injections, then offers surgery if needed. The other plan goes straight to surgery. About 258 adults with mild to moderate symptoms will…
Phase: PHASE4 • Sponsor: Diakonhjemmet Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Nurse-Led video care may ease daily life for rare Parkinson's forms
Symptom relief OngoingThis study tests whether a home-based telenursing program, led by a specialist nurse, can improve quality of life and reduce complications like falls for people with atypical parkinsonism (MSA or PSP). About 164 participants will receive proactive and reactive remote monitoring a…
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Soundwave therapy shows promise for chemo nerve damage
Symptom relief OngoingThis study tests a device called SensoniQ® Treatment Station that uses low frequency soundwaves to prevent or reduce nerve pain caused by chemotherapy in people with gynecologic cancer. The trial includes 80 participants, some starting chemo and others with lasting nerve pain. Re…
Phase: NA • Sponsor: Augusta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Capsaicin patch trial targets nerve pain in lower back and legs
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether Qutenza 8% capsaicin skin patches can safely and effectively treat nerve-related lower back pain and leg pain (sciatica). Fifty adults with symptoms lasting over three months will receive up to four patches per visit over five visits in a year. The main g…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Could a tiny nerve zap restore erectile function?
Symptom relief OngoingThis study tests whether low-dose electrical stimulation of the pudendal nerve can improve erectile function in men with mild to moderate erectile dysfunction. Twenty-four men will receive a 20-minute stimulation session, and researchers will measure changes in erection hardness,…
Phase: NA • Sponsor: Camilo Jose Cela University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Pelvic floor exercises tested as pain relief for nerve condition
Symptom relief ENROLLING_BY_INVITATIONThis study compares a 6-month physiotherapy program focused on pelvic floor relaxation to no structured exercise in women with pudendal neuralgia, a chronic pelvic pain condition. Researchers will measure muscle stiffness using ultrasound and track symptoms like pain and sexual d…
Phase: NA • Sponsor: Comenius University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Could a short steroid course after surgery reduce pain and nausea?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether a 6-day course of oral steroids after orthopedic surgery can help reduce pain, nausea, and improve movement. About 500 adults having common surgeries like joint replacement or fracture repair will be randomly assigned to receive either standard care or…
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Magnetic pulses to the brain may ease stubborn nerve pain
Symptom relief OngoingThis study tests whether repeated magnetic pulses (rTMS) aimed at the brain's motor area can safely reduce chronic nerve pain that hasn't responded to other treatments. About 32 adults with conditions like post-stroke pain, trigeminal neuralgia, or spinal cord injury will receive…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Massage may ease chemo nerve damage
Symptom relief OngoingThis study looks at whether massage therapy can reduce nerve problems like pain, numbness, and tingling caused by chemotherapy in people with breast or digestive system cancers. About 90 participants will receive massage sessions to see if it improves symptoms and quality of life…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Micro-Implant zaps nerve pain: new hope for chronic sufferers?
Symptom relief OngoingThis study tests a small, implantable device that stimulates nerves to relieve chronic pain after injury or surgery. About 185 adults with peripheral neuralgia will either receive the stimulator plus standard medical care or standard care alone. The goal is to see if the device p…
Phase: NA • Sponsor: Nalu Medical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Online support groups and telemedicine aim to ease Parkinson's and dementia burden
Symptom relief OngoingThis study looks at whether online community support and telemedicine can improve quality of life for people with Parkinson's disease, Lewy body dementia, and related conditions, as well as their caregivers. About 632 participants will receive palliative care training for their d…
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Which shot works better for pinched nerve pain in the neck?
Symptom relief OngoingThis study looked back at medical records of 330 adults with cervical radiculopathy (pinched nerve in the neck causing pain down the arm). It compared two types of injections: one guided by ultrasound and one guided by X-ray. The goal was to see which method reduces pain more, sp…
Phase: NA • Sponsor: Pusan National University Yangsan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New hope for shingles pain sufferers: drug trial underway
Symptom relief OngoingThis study tests an experimental drug called ONO-1110 to see if it can safely reduce pain in people with postherpetic neuralgia, a type of nerve pain that persists after a shingles infection. About 140 Japanese adults with pain lasting at least 3 months will receive either the dr…
Phase: PHASE2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Facial paralysis hope: new rehab techniques tested
Symptom relief OngoingThis study tests whether adding Kabat rehabilitation or kinesiology taping to standard facial therapy helps people with Bell's palsy recover better. 38 adults with one-sided facial paralysis will receive one of the two extra treatments for 8 weeks. Researchers will measure change…
Phase: NA • Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Brain training offers new hope for chemo nerve pain
Symptom relief OngoingThis study tests whether a non-invasive therapy called neurofeedback can help people with chemotherapy-induced nerve pain learn to change their own brain waves to feel less pain. About 80 participants will be assigned to either receive neurofeedback training or a control conditio…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Exercise may ease pain in lung cancer survivors, small study hopes
Symptom relief OngoingThis study tests whether a progressive exercise program can reduce chronic pain in veteran lung cancer survivors aged 60-80. Nine participants will do treadmill walking, resistance bands, and balance exercises. The goal is to see if exercise can be a safe alternative to opioids f…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Yoga vs. nerve pain: could stretching replace pills for chemo side effects?
Symptom relief OngoingThis study tests whether yoga can reduce nerve pain caused by chemotherapy in cancer survivors. About 227 participants will either take yoga classes twice a week for 8 weeks, attend educational sessions, or receive standard care. Researchers will measure pain, balance, fall risk,…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Acupuncture needles take on chemo nerve pain in major trial
Symptom relief OngoingThis study tests if acupuncture can reduce nerve pain caused by chemotherapy in cancer survivors. About 255 people who finished chemo at least three months ago will receive either real or sham acupuncture. The goal is to see if this drug-free approach can ease pain and improve da…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Sound waves zapping pain: new hope for facial neuralgia?
Symptom relief OngoingThis early-phase study tests whether MRI-guided focused ultrasound can safely reduce severe facial pain in people with trigeminal neuralgia that hasn't responded to medication. Ten adults aged 21-75 with chronic pain for over 6 months will receive a precise ultrasound treatment t…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New pill could ease the 'Suicide Disease' for patients failed by current meds
Symptom relief OngoingThis study tests a daily drug called basimglurant for adults with trigeminal neuralgia, a condition causing severe facial pain often called the 'suicide disease.' The trial includes 166 people who still have pain despite current treatments. After an 8-week run-in on the drug, par…
Phase: PHASE2, PHASE3 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Art therapy may ease symptoms of rare brain disease
Symptom relief OngoingThis study explores whether art therapy can help people with progressive supranuclear palsy (PSP) feel better and improve their daily life. Ten participants will take part in art sessions, and researchers will measure changes in quality of life, mood, and caregiver stress. The go…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Could a 12-minute electrical zap ease your numb fingers?
Symptom relief OngoingThis study looks at whether a type of electrical current called diadynamic current can reduce pain and improve hand function in people with carpal tunnel syndrome. About 80 adults with mild to moderate carpal tunnel syndrome will receive this therapy along with standard care like…
Phase: NA • Sponsor: Duzce University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Massage showdown: which therapy eases piriformis pain best?
Symptom relief ENROLLING_BY_INVITATIONThis study compares two types of hands-on therapy—Stecco Fascial Manipulation and Rolfing Structural Integration—for people with piriformis syndrome, a condition that causes buttock and leg pain. Forty-two adults aged 25 to 45 with at least four weeks of pain will receive four we…
Phase: NA • Sponsor: Danyal Ahmad • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Can a 10-Minute breathing app tame migraines?
Symptom relief ENROLLING_BY_INVITATIONThis study tests an 8-week app-based breathing program that uses heart rate feedback to help people with chronic migraine. Thirty adults will use the app daily for 10 minutes, and researchers will track changes in migraine frequency and psychological well-being. The goal is to se…
Phase: NA • Sponsor: Arizona State University • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Could a gentle zap to the spine ease chronic nerve pain?
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a noninvasive electrical stimulation device placed on the skin over the spine can reduce pain and improve quality of life in people with neuropathic (nerve) pain. About 62 adults with chronic low back pain from nerve damage will receive either real or sha…
Phase: NA • Sponsor: Nanchang University Affiliated Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Migraine drug could soothe stubborn facial pain
Symptom relief ENROLLING_BY_INVITATIONThis small study tests whether eptinezumab, a drug used for migraines, can reduce pain in people with atypical facial pain that hasn't responded to other treatments. Ten participants will receive two intravenous infusions three months apart. The main goal is to see if the drug im…
Sponsor: Alenka Spindler-Vesel • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Can herbs and spinal manipulation ease chronic back pain? new study investigates
Symptom relief OngoingThis study looks at whether a combination of herbal medicine and Chuna manual therapy (a Korean spinal manipulation technique) can safely reduce pain and improve walking ability in people with low back pain or sciatica caused by lumbar spinal stenosis or spondylolisthesis. Resear…
Sponsor: Jaseng Medical Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Can ketamine ease chronic pain? new study seeks answers
Symptom relief ENROLLING_BY_INVITATIONThis study looks at adults with chronic pain who receive ketamine infusions at Stanford's Pain Management Center. Researchers want to understand which patients improve and what factors predict a good response. The goal is to better tailor this treatment to individuals.
Sponsor: Theresa Lii • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New pain relief for diabetic nerves? trial pulled before start
Symptom relief TerminatedThis study was designed to test a new drug called N0750 against two standard pain medications (Cymbalta and Lyrica) for painful diabetic peripheral neuropathy. It planned to enroll adults with diabetes and nerve pain for at least 3 months. However, the trial was withdrawn before …
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Ear acupressure shows promise for chemo nerve damage
Symptom relief OngoingThis study tests whether pressing specific points on the ear (auricular point acupressure) can reduce pain, numbness, and tingling caused by chemotherapy. About 225 cancer patients will try this non-needle technique. Researchers will also measure changes in nerve function and bod…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Simple stretches may ease piriformis pain: new study
Symptom relief OngoingThis study looks at whether adding dynamic stretching to foam rolling helps people with piriformis syndrome more than foam rolling alone. Forty adults aged 35–50 with buttock pain will do either foam rolling or foam rolling plus dynamic stretches for several weeks. Researchers wi…
Phase: NA • Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New combo drug aims to ease nerve pain in diabetes
Symptom relief OngoingThis study tests whether a new medicine called CagriSema can reduce nerve pain in people with type 2 diabetes. About 142 adults with painful diabetic neuropathy will receive either CagriSema or a placebo for around 10 months. The main goal is to see if the drug lowers weekly pain…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Head-to-Head: which drug tames facial nerve pain better?
Symptom relief OngoingThis study compares carbamazepine and oxcarbazepine, two drugs used to treat trigeminal neuralgia, a condition causing severe facial pain. Researchers will enroll 122 adults aged 18-60 who have had the condition for at least two weeks. They will measure pain relief using a standa…
Phase: NA • Sponsor: Abbasi Shaheed Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Could a baby's birth sac help heal your neck after surgery?
Symptom relief ENROLLING_BY_INVITATIONThis study tests if a wrap made from donated birth tissue (amniotic membrane) can reduce swelling after a two-level neck fusion surgery. About 50 adults with neck spine problems will take part. The main goal is to see if the wrap lessens soft tissue swelling one month after surge…
Phase: NA • Sponsor: AlloSource • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Green light therapy: a new hope for chronic pain sufferers?
Symptom relief OngoingThis study tests whether daily exposure to green LED light can reduce chronic pain. 55 adults with conditions like fibromyalgia or nerve pain will use a green or white light device at home for 2 hours each day over 3 months. Researchers will measure changes in pain levels, medica…
Phase: NA • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New spinal device offers hope for diabetic leg pain
Symptom relief ENROLLING_BY_INVITATIONThis study tests a new way of using spinal cord stimulation to treat long-lasting leg pain caused by diabetic nerve damage. Up to 25 adults with severe pain will first try a temporary device, and if it helps, they can get a permanent implant. The main goal is to see if this appro…
Phase: NA • Sponsor: TriCity Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Face mask zaps nerve pain: new hope for trigeminal neuralgia?
Symptom relief OngoingThis study tests a precise radiation treatment for trigeminal neuralgia, a condition that causes severe facial pain. Instead of a metal frame screwed into the skull, a special face mask holds the head still while x-rays target the painful nerve. The trial includes 40 adults whose…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Brain wave therapy may ease chemo nerve pain
Symptom relief OngoingThis study tests whether neurofeedback training—a non-invasive therapy that uses brain wave monitoring—can help people with chemotherapy-induced peripheral neuropathy (nerve pain, numbness, or tingling) learn to change their own brain activity to feel less pain and improve qualit…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Magnetic pulses to the brain may soothe chemo nerve damage
Symptom relief OngoingThis study tests if a non-invasive treatment called repetitive transcranial magnetic stimulation (rTMS) can reduce nerve pain caused by oxaliplatin chemotherapy in people with stage I-IV cancer. rTMS uses magnetic pulses on the scalp to change brain activity. The trial includes 5…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New wrap may shield nerves during second elbow surgery
Symptom relief OngoingThis study looks at whether a special nerve wrap can help people who need a second surgery for cubital tunnel syndrome, a condition where a nerve in the elbow gets compressed. Twenty adults with ongoing pain or numbness after their first surgery will receive the nerve protector d…
Phase: NA • Sponsor: Axogen Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New combo therapy aims to ease leg swelling in nerve disorder patients
Symptom relief OngoingThis study tests whether combining two non-invasive therapies—infrared light (MIRE) and electrical nerve stimulation (TENS)—can reduce leg swelling caused by nerve-related blood flow problems. About 1000 adults with lower leg swelling took part. The main goal is to see if the tre…
Phase: NA • Sponsor: American Association of Sensory Electrodiagnostic Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Desperate patient gets own stem cells for rare nerve disease
Symptom relief NO_LONGER_AVAILABLEThis study treated one 58-year-old man with polyneuropathy caused by POEMS syndrome using his own fat-derived stem cells. He received eight infusions over 28 weeks to try to relieve nerve symptoms. The study is no longer available and was not a formal clinical trial.
Sponsor: Hope Biosciences Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Could body fat ease carpal tunnel pain? new study investigates
Symptom relief TerminatedThis study tests whether injecting a patient's own fat (lipografting) into the wrist can improve symptoms of mild to moderate carpal tunnel syndrome better than standard steroid injections. The fat is thought to reduce scarring and help nerves glide more freely. The trial plans t…
Phase: EARLY_PHASE1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Laser light could help Bell's palsy patients smile again
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether low level laser therapy can improve facial function in people with Bell's palsy, a condition that causes sudden facial weakness. Researchers will compare laser therapy to routine physiotherapy in 100 adults aged 18 to 80. The main goal is to see if laser …
Phase: NA • Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can a natural supplement soothe chemo nerve damage?
Symptom relief OngoingThis phase II trial tests whether a natural supplement called PEA can relieve nerve pain, numbness, and tingling caused by chemotherapy in cancer patients. About 88 adults who have had nerve symptoms for at least 3 months after chemo will take PEA or a placebo for 8 weeks. The st…
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Baking soda in numbing shots could ease carpal tunnel surgery pain
Symptom relief OngoingThis study tests whether adding sodium bicarbonate (baking soda) to the local anesthetic used during carpal tunnel release surgery reduces the pain of the injection itself. 116 adults with carpal tunnel syndrome will be randomly assigned to receive either buffered or standard ane…
Phase: NA • Sponsor: Kuopio University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 18:40 UTC
-
Which stitch leaves a better scar after carpal tunnel surgery?
Symptom relief OngoingThis study compares two common types of stitches used to close the wound after carpal tunnel release surgery: absorbable stitches that dissolve on their own and non-absorbable stitches that need to be removed. About 116 patients will be randomly assigned to one stitch type, and t…
Phase: NA • Sponsor: Kuopio University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 18:34 UTC
-
Can a posture device replace surgery for cubital tunnel syndrome?
Symptom relief TerminatedThis study tests whether the UpRight Go posture trainer, a wearable device that vibrates when you slouch, can reduce pain, numbness, and weakness in people with cubital tunnel syndrome who haven't had surgery. Researchers at Yale University plan to enroll 40 adults and track symp…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 26, 2026 17:38 UTC
-
Zapping away chemo pain: new device trial offers hope
Symptom relief ENROLLING_BY_INVITATIONThis study tests a non-invasive brain stimulation technique called prolonged continuous theta burst stimulation (pcTBS) to relieve nerve pain caused by chemotherapy in breast cancer patients. Forty women will receive either pcTBS or standard repetitive transcranial magnetic stimu…
Phase: NA • Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation • Aim: Symptom relief
Last updated Jun 26, 2026 15:44 UTC
-
Light therapy tested for Post-Mastectomy nerve pain – but study never started
Symptom relief TerminatedThis study planned to test photobiomodulation (a type of light therapy) on nerve pain and sensation in one woman after mastectomy. The treatment used red and near-infrared light on the affected area for six weeks. However, the study was withdrawn before any participants enrolled,…
Phase: NA • Sponsor: Tufts University • Aim: Symptom relief
Last updated Jun 26, 2026 14:31 UTC
-
Can simple nerve stretches ease diabetic burning pain?
Symptom relief ENROLLING_BY_INVITATIONThis study tests two types of nerve stretches—active (patient-controlled) and passive (therapist-applied)—to see which better reduces burning pain, improves muscle strength, and increases joint movement in people with diabetic neuropathy. Sixty adults aged 40 to 65 with diabetes …
Phase: NA • Sponsor: Dow University of Health Sciences • Aim: Symptom relief
Last updated Jun 26, 2026 12:43 UTC
-
Brain scans reveal secrets of lost smell
Knowledge-focused ENROLLING_BY_INVITATIONThis study tracks 80 adults with different smell disorders (like total loss, partial loss, or distorted smell) plus healthy volunteers over one year. Researchers use brain scans, smell tests, and questionnaires to see how the brain changes and how smell loss impacts mood and dail…
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Brain scan study tracks why Parkinson's patients fall and forget
Knowledge-focused OngoingThis study follows 125 people with Parkinson's disease or related conditions over two years. Researchers use special brain scans to measure changes in a chemical called acetylcholine, which is linked to walking problems, falls, and thinking skills. The goal is to understand how t…
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Flat feet may be tied to a common cause of hip pain, study suggests
Knowledge-focused OngoingThis study looks at whether people with flat feet (pes planus) are more likely to have piriformis syndrome, a condition that causes pain in the hip and lower back. Researchers will compare foot posture and pain in adults aged 18-65 who have piriformis syndrome with those who do n…
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists Fine-Tune diagnostic tools for autonomic nervous system disorders
Knowledge-focused OngoingThis study aims to improve how doctors test for autonomic failure, a condition where the body's automatic functions like blood pressure control don't work properly. Researchers will use advanced imaging, sweat tests, and skin biopsies in up to 89 adults with Parkinson's disease, …
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Zapped nerves: study planned to boost recovery after surgery — but never started
Knowledge-focused TerminatedThis study was designed to see if giving a short, mild electrical stimulation to compressed nerves during surgery could speed up recovery of strength and function. It planned to include people with nerve compression in the spine or limbs who were already scheduled for decompressi…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
10-Year NF1 study aims to unlock secrets of rare genetic disorder
Knowledge-focused OngoingThis natural history study follows 259 children, adolescents, and adults with Neurofibromatosis Type 1 (NF1) for up to 10 years. Researchers will track tumor growth, monitor quality of life, and perform genetic testing to better understand how the disease changes over time. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists hunt for clues to diagnose Parkinson's earlier
Knowledge-focused OngoingThis study aims to identify biomarkers—biological clues in the body—that can help distinguish between Parkinson's disease and similar conditions like progressive supranuclear palsy and multiple system atrophy. Researchers will follow people with early-stage parkinsonism and healt…
Sponsor: Non-profit organization for scientific research in Parkinson's disease and related disorders • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can DNA tests pick the right cancer drug for kids?
Knowledge-focused OngoingThis study screens children and teens with advanced solid tumors, lymphomas, or histiocytic disorders to find genetic changes in their cancer cells. Participants undergo biopsies and scans to identify mutations that can be targeted by specific drugs. The goal is to see if matchin…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Braces breakthrough? study tests which wire moves teeth faster
Knowledge-focused ENROLLING_BY_INVITATIONThis study compares stainless steel and titanium-molybdenum alloy wires for moving canine teeth in people with braces. Sixteen participants will have one type of wire on each side of their upper jaw to see which works better. The goal is to find out which wire moves teeth more ef…
Phase: NA • Sponsor: Tanzila Rafique • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Major study tracks Real-World MG care in china
Knowledge-focused OngoingThis study follows about 1,200 people with myasthenia gravis (MG) across China to understand how the disease is treated in real-world clinics. Researchers will track symptoms, daily living abilities, quality of life, and healthcare use every 6 months until 2027. The goal is to le…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can sound waves tame the autonomic nervous system?
Knowledge-focused ENROLLING_BY_INVITATIONThis study explores whether low-intensity focused ultrasound (LIFU) aimed at specific brain regions can influence how the body controls automatic functions like heart rate and blood pressure. Researchers will apply LIFU or a sham (fake) version to 80 volunteers and measure change…
Phase: NA • Sponsor: Virginia Polytechnic Institute and State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Healthy volunteers needed to map the Body's 'Autopilot' system
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to better understand the autonomic nervous system (ANS), which controls things like heart rate and breathing without us thinking about it. Researchers will use simple, noninvasive tests (like cold water and deep breathing) to measure how the ANS responds in 48 hea…
Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Massive study aims to unlock secrets of childhood nerve and muscle diseases
Knowledge-focused OngoingThis long-term study looks at children and adults with inherited nerve and muscle disorders that start early in life, like muscular dystrophy. Researchers will track symptoms over time and collect genetic samples from affected individuals, their family members, and healthy volunt…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Major study launches to unravel the Real-World impact of rare nerve disease
Knowledge-focused OngoingThis study follows about 413 adults with multifocal motor neuropathy (MMN) over time to learn how the disease progresses and affects daily life. Researchers will collect information on symptoms, quality of life, and healthcare use during regular doctor visits. No experimental tre…
Sponsor: argenx • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Hidden heart risk in kids with diabetes: new study investigates
Knowledge-focused OngoingThis study examines how common cardiac autonomic neuropathy (nerve damage affecting the heart) is in children and teens with type 1 diabetes. Researchers will monitor 75 participants using heart tests and check if longer diabetes duration or poor blood sugar control raises the ri…
Phase: NA • Sponsor: Marwa Abouelela Abd Elsalam • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to perfect how we measure muscle recovery in ICU survivors
Knowledge-focused OngoingThis study looks at whether a tool called the Chelsea Critical Care Physical Assessment tool (CPAx) can accurately track recovery in 120 adults who developed muscle weakness after being on a breathing machine in the ICU. The goal is to find the smallest meaningful improvement tha…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Brain monitor may guide safer blood pressure during surgery
Knowledge-focused OngoingThis study looks at whether low blood pressure during major noncardiac surgery harms organs like the heart and kidneys. Researchers are using a non-invasive brain monitor to see if a personalized blood pressure target can be set. 650 patients at cardiovascular risk are being obse…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
War wounds may trigger hidden heart risks, new study reveals
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how serious combat injuries affect the long-term health of U.S. military members. Researchers will measure heart function, sleep quality, and stress-related body signals in 200 injured service members. The goal is to understand links between injury severity, s…
Sponsor: Uniformed Services University of the Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Blood pressure clues may predict early death after heart attack
Knowledge-focused OngoingThis study examines whether a low pulse pressure (the difference between top and bottom blood pressure numbers) in the first hours after a cardiac arrest is linked to early death. Researchers will analyze data from 3500 patients who had a cardiac arrest outside the hospital and a…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Blood marker may predict nerve damage onset in rare genetic disease
Knowledge-focused OngoingThis observational study is looking at a protein called neurofilament light chain (NfL) in the blood of people who carry a gene variant for hereditary ATTR amyloidosis, both those without symptoms and those with nerve damage. Researchers want to see if NfL levels can help detect …
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Reading to babies: a surprising boost for tiny hearts and brains?
Knowledge-focused OngoingThis pilot study from Tulane University tests whether a mother reading aloud to her newborn can positively affect the baby's autonomic nervous system. One healthy newborn and mother will have their heart activity measured during reading sessions. The goal is to see if live readin…
Phase: NA • Sponsor: Tulane University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Brain radiation and memory: new study maps hidden risks
Knowledge-focused OngoingThis study follows 75 adults with benign or slow-growing brain tumors who are receiving partial brain radiation. Researchers will use memory tests and MRI scans before treatment and at 6 and 12 months after to see how radiation affects thinking and memory. The goal is to identify…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Researchers hunt for clues: do our own antibodies harm nerves?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether the immune system mistakenly makes antibodies that attack the body's own nerves and muscles in people with multiple sclerosis, myasthenia gravis, and similar conditions. Researchers will collect blood samples (and sometimes cheek swabs) from 120 adults…
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Scientists map Brain's 'Roads' to predict dementia spread
Knowledge-focused ENROLLING_BY_INVITATIONThis study uses advanced MRI scans and genetic tests to track how neurodegenerative diseases like frontotemporal dementia and ALS spread across the brain's network. Researchers will follow 645 participants, including patients, family members, and healthy controls, for up to 2 yea…
Phase: NA • Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Sugar water injection may reveal hidden strength in drop foot patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether a simple injection of sugar water (D5W) can reliably bring out a hidden sign of muscle strength in people with drop foot. Researchers will inject the fluid under the skin and check muscle strength before and after. The goal is to see if this test can h…
Phase: NA • Sponsor: US Neuropathy Centers • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Could light make cochlear implants hear better?
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new type of cochlear implant that uses light instead of electricity to stimulate the hearing nerve. Researchers hope light can target smaller nerve groups, leading to clearer sound. The trial involves 30 adults who are already having ear surgery for tumor remov…
Phase: NA • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Med student stress may be tied to wrist pain, new study suggests
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether anxiety and depression are connected to carpal tunnel syndrome in medical students. Researchers will measure the median nerve in the wrist and check students' anxiety and depression levels using questionnaires. The goal is to see if there is a link bet…
Sponsor: University of Ioannina • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Blood test could revolutionize sarcoma monitoring
Knowledge-focused OngoingThis study is testing whether a liquid biopsy (a blood test that detects tumor DNA) can help predict outcomes for people with Ewing sarcoma or osteosarcoma. Researchers will collect blood samples from 340 patients at diagnosis and track their health over time. The goal is to see …
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Pandemic's toll on cancer patients with neuropathy under the microscope
Knowledge-focused OngoingThis study looks at how the COVID-19 pandemic impacted the quality of life of 274 cancer patients who also have neuropathy (nerve pain). All participants had taken part in earlier clinical trials. Researchers want to see if there are differences between those who received a brain…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Leg stretch may alter nerve pain sensitivity, tiny study hints
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether a specific leg stretching technique, called sciatic nerve mobilization, can change how sensitive the nerves in your lower leg are to pressure pain. 34 healthy university students will either receive the stretch or no treatment. Researchers will measure pa…
Phase: NA • Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Childhood cancer Survivors' heart health under the microscope
Knowledge-focused TerminatedThis study was designed to understand heart rate and sleep issues in adults who survived childhood cancer. Researchers planned to use a smartphone app and wearable device to compare survivors with their siblings. The goal was to identify who is most at risk and develop ways to pr…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to catch diabetic nerve damage earlier
Knowledge-focused ENROLLING_BY_INVITATIONThis study will measure nerve signals in 50 adults aged 45 to 76 with diabetic peripheral neuropathy. Researchers will compare these signals with blood sugar levels, diabetes duration, and neuropathy symptom scores. The goal is to find better ways to detect nerve damage early.
Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Decision aids may ease patient uncertainty in hand surgery
Knowledge-focused TerminatedThis study tests whether giving patients with hand problems like carpal tunnel syndrome or trigger finger a decision aid—a booklet with clear information about their condition and treatment options—helps them feel more satisfied and less conflicted about their choices. About 126 …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a simple scale accurately measure hand problems in carpal tunnel syndrome?
Knowledge-focused ENROLLING_BY_INVITATIONThis study is checking whether a questionnaire called the MAP-Hand scale is a valid and reliable way to measure hand activity in people with carpal tunnel syndrome. Researchers will enroll 180 adults with mild or moderate carpal tunnel syndrome and compare their scale results to …
Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists probe brain changes behind chronic pain
Knowledge-focused OngoingThis study looks at how the nervous system becomes overly sensitive in people with different types of chronic pain. Researchers will assess 185 adults using questionnaires, thinking tests, and laser brain-wave measurements at the start and after one year. The goal is to better un…
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Can your genes predict chemo nerve pain?
Knowledge-focused OngoingThis study looks at how a person's genes and medical history might help predict nerve damage caused by chemotherapy. Researchers will follow 300 people with certain cancers who are scheduled for specific chemo drugs. The goal is to find patterns that could help prevent or reduce …
Sponsor: National Cheng-Kung University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New cage for neck surgery under observation – no treatment given
Knowledge-focused OngoingThis study watches 24 adults who are getting standard neck fusion surgery with a special device called the BEE HA cage. The goal is to see how well the cage helps with pain and function over time. No new treatment is tested—just careful tracking of normal surgery results.
Sponsor: Invibio Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Brain wave study on ketamine for pain withdrawn before starting
Knowledge-focused TerminatedThis study was designed to observe brain wave (EEG) changes in adults with chronic neuropathic pain during ketamine treatment. Researchers hoped to find patterns that could predict which patients benefit most. However, the study was withdrawn before enrolling any participants, so…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Back pain breakthrough? study seeks clues to who benefits from nerve scar treatment
Knowledge-focused OngoingThis study reviews medical records of 40 adults with chronic leg pain from back problems who had a procedure called caudal epidural adhesiolysis. The procedure uses a thin tube to break up scar tissue around spinal nerves. Researchers want to find out which patient traits or proc…
Sponsor: Mersin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Brain training with mirrors and zaps: new hope for nerve injury recovery?
Knowledge-focused OngoingThis study looks at how combining mirror therapy, electrical stimulation, and motor imagery changes brain activity in people with recent forearm nerve injuries and in healthy adults. Researchers want to understand if these therapies can help the brain adapt better after injury. T…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Can online care help kids with nervous system disorder?
Knowledge-focused ENROLLING_BY_INVITATIONThis pilot study looks at whether it is possible to use online surveys and remote complementary healthcare sessions for children with dysautonomia, a condition that affects the automatic nervous system. Twenty children aged 5-14 will receive NERVE therapy and complete online asse…
Sponsor: Life University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
New study seeks to predict muscle weakness in ICU kids before it strikes
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to find early biological markers that can predict muscle weakness in children who need a breathing machine in the intensive care unit. About 500 children will be observed to see who develops this condition. The goal is to create a warning system so doctors can int…
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
ICU physiotherapy under the microscope: can we measure its true cost?
Knowledge-focused OngoingThis study looks at how much energy critically ill patients on ventilators use during routine passive physiotherapy. By measuring oxygen consumption with a special device in the breathing tube, researchers hope to understand the physical demands of these exercises. The goal is to…
Sponsor: Universidad de Extremadura • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New study aims to predict muscle weakness in kids on ventilators before it strikes
Knowledge-focused ENROLLING_BY_INVITATIONThis study is developing an early warning model to predict ICU-acquired weakness in children who need mechanical ventilation. Researchers will track 1,500 children in the PICU, looking for biomarkers and other signs that could forecast muscle weakness. The goal is to move from di…
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New study tracks Long-Term safety of NF1 drug in kids
Knowledge-focused OngoingThis study monitors the safety of selumetinib in children aged 3 to 18 with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas. Researchers will track potential side effects on the heart, bones, muscles, liver, eyes, and puberty. The goal is to better un…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New study aims to catch brain damage in babies after heart surgery
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 30 infants with congenital heart disease who need heart surgery. Researchers will use blood tests, EEG brain wave monitoring, and MRI scans to look for signs of brain injury. The goal is to find better ways to detect brain damage early and identify which childr…
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Stitch showdown: which suture leaves a better scar after hand surgery?
Knowledge-focused TerminatedThis study aimed to see if using stitches that dissolve (absorbable) or stitches that need removal (non-absorbable) leads to better scar appearance and patient satisfaction after carpal tunnel or trigger finger surgery. It was planned for adults having these common hand surgeries…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Could a common heart pill delay Parkinson's? small study hints at possibility
Knowledge-focused OngoingThis study looks at whether carvedilol, a drug used for heart failure, can reverse early heart changes seen in people with a sleep disorder that puts them at high risk for Parkinson's disease. Fifteen participants with REM sleep behavior disorder or reduced sense of smell will ta…
Phase: PHASE2 • Sponsor: Michele Tagliati, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
AI and VR join forces to fight severe facial pain
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at people with trigeminal neuralgia, a condition that causes severe facial pain. Researchers want to see if adding virtual reality (VR) training before Gamma Knife surgery can improve pain relief. They will also use artificial intelligence (AI) and brain scans to…
Phase: NA • Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Scientists use chili peppers and ice water to unlock headache secrets
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how headaches work by using capsaicin (the spicy part of chili peppers) and ice water to trigger mild, temporary pain in people with and without headache disorders. Researchers measure changes in pain signals and tear production to better understand conditions…
Phase: PHASE1 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Spine surgery spark: could a jolt of electricity help patients regain bladder control?
Knowledge-focused OngoingThis study explores whether a short burst of electrical stimulation applied during and after spine surgery can help nerves recover in people with cauda equina syndrome, a condition that can cause bladder, bowel, and sexual problems. About 40 adults having emergency surgery will r…
Phase: NA • Sponsor: University of Liverpool • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Scientists dig into the Body's wiring after COVID: what causes POTS?
Knowledge-focused OngoingThis study looks at what happens in the body to cause POTS and dysautonomia after viral infections, including COVID-19. About 100 women will give a blood sample and share medical records. Researchers will study immune system markers to find clues that could lead to better diagnos…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Vagus nerve study for autism withdrawn before starting
Knowledge-focused TerminatedThis study planned to test vagus nerve stimulation (VNS) in children and adults with autism and developmental disabilities to see if it could improve behavior, thinking, and body rhythms. Participants would have chosen 1 to 3 months of daily VNS and completed monthly check-ins. T…
Phase: NA • Sponsor: New York State Institute for Basic Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Thousands tracked after carpal tunnel surgery: does new device deliver?
Knowledge-focused OngoingThis study is tracking 2000 adults with carpal tunnel syndrome who are having surgery to release the nerve. The surgery uses a special device called UltraGuideCTR, which is guided by ultrasound. Researchers are collecting real-world data on symptoms and hand function for up to 24…
Sponsor: Sonex Health, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Eye pain mystery: scientists probe nerve link in dry eye sufferers
Knowledge-focused TerminatedThis study looks at how common nerve problems are in people who feel eye discomfort. Researchers will test 1,000 participants to see if their pain is linked to nerve damage rather than just dry eye. The goal is to better understand these conditions and improve diagnosis.
Sponsor: Tufts Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Scientists track rare eye disease to uncover clues for future treatments
Knowledge-focused OngoingThis study follows 46 people with gyrate atrophy, a rare genetic condition that causes vision loss, over 4 years. Researchers measure ornithine levels in the blood and track changes in the retina using eye scans and photos. The goal is to learn how the disease progresses under st…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
New ultrasound could better track carpal tunnel recovery
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new ultrasound technique called shear wave elastography to measure stiffness in the wrist nerves and tissues of people with carpal tunnel syndrome. Researchers will compare these measurements with standard tests before and after treatment (surgery or steroid in…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Wearable tech aims to track rare brain diseases from home
Knowledge-focused OngoingThis study is testing whether wearable sensors can reliably monitor movement problems in people with progressive supranuclear palsy (PSP) and related frontotemporal disorders. About 60 participants will wear pendant-like devices for 12 months to track their activity. The goal is …
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
POTS brain fog targeted in new drug study
Knowledge-focused OngoingThis early-phase study tests whether a single dose of modafinil, a drug that promotes wakefulness, can improve concentration and mental clarity in people with Postural Tachycardia Syndrome (POTS). About 20 adults diagnosed with POTS will take the drug and then complete computer-b…
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New study aims to predict cancer risk in NF1 patients before it strikes
Knowledge-focused OngoingThis study follows 80 people with Neurofibromatosis type 1 (NF1) who are at high risk for developing malignant peripheral nerve sheath tumors (MPNST). Researchers will use yearly whole-body MRI scans, blood samples, and checkups to track changes in nerve lesions over time. The go…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
AI chatbot tested to help patients decide on tumor treatment
Knowledge-focused TerminatedThis study looked at whether ChatGPT could help patients with vestibular schwannoma (a non-cancerous ear tumor) feel less confused and more confident about their treatment choices. It planned to compare decision-making scores between a group trained to use ChatGPT and a group tha…
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New eye test could unlock secrets of ocular pain
Knowledge-focused TerminatedThis study looks at how well a new test called quantitative sensory testing (QST) can measure nerve function in the eye. Researchers will use heat, cold, and vibration to see how people with dry eye disease or corneal nerve damage respond. The goal is to better understand eye pai…
Phase: NA • Sponsor: Tufts Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Silent tumors may still harm the heart, new study warns
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at people with rare adrenal tumors (pheochromocytomas and paragangliomas) that do not produce excess hormones. Researchers want to see if these 'silent' tumors still cause heart problems, blood pressure changes, or metabolic issues like diabetes and high choleste…
Sponsor: Laikο General Hospital, Athens • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Massive gene hunt launched for mysterious mitochondrial diseases
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to discover new genetic mutations that cause mitochondrial disorders by analyzing tissue samples from up to 6,900 participants. It includes people with suspected or known mitochondrial diseases, such as MELAS or Leigh's Disease, who lack a genetic diagnosis. The r…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Could hidden antibodies be causing your gut problems?
Knowledge-focused OngoingThis study aims to find new antibodies that may cause autoimmune gastrointestinal motility disorders, where the gut doesn't move food properly. Researchers will collect blood samples from 300 patients with chronic gut symptoms to look for these antibodies. The goal is to better u…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Heart check: do Nerve-Targeting drugs also shield the heart in rare amyloidosis?
Knowledge-focused OngoingThis study follows 20 adults with hereditary transthyretin amyloidosis (ATTRv) who have both nerve and heart involvement. They are treated with patisiran or vutrisiran for two years. Researchers use MRI scans and questionnaires to see how the drugs affect heart structure and func…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Researchers probe hidden jaw pain in nerve disorder patients
Knowledge-focused TerminatedThis study aimed to find out how many people with trigeminal neuralgia (a severe facial nerve pain condition) also have temporomandibular disorder (TMD), which causes jaw pain. Researchers planned to follow patients from three clinics and test a questionnaire to better diagnose b…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Can a glass of water or a change in posture spike your eye pressure?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how changing your body position or drinking water can cause temporary spikes in eye pressure. Researchers will measure these changes in healthy volunteers and in people with glaucoma or autonomic dysfunction. The goal is to better understand what challenges th…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New pathway aims to cut wait times for carpal tunnel patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether a new care pathway can shorten wait times for people with carpal tunnel syndrome. Researchers will compare wait times before and after the pathway is put in place. About 200 adults will take part and fill out a short satisfaction survey.
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Spine surgery safety under the microscope: new study watches Real-World results
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 150 adults undergoing back-of-the-neck and upper spine surgery with metal screws and rods (posterior fixation) for injuries, tumors, or worn-out discs. Researchers track complications, X-ray results, and patient-reported pain over time. The goal is to better un…
Sponsor: NuVasive • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Brain insulin study seeks healthy volunteers
Knowledge-focused TerminatedThis study looks at how insulin in the brain changes blood flow and nerve signals in healthy adults aged 18-45. Researchers will measure blood flow in the brain and legs, as well as nerve activity. The goal is to understand basic body functions, not to treat any disease.
Phase: EARLY_PHASE1 • Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New imaging method could spot hidden cancers
Knowledge-focused OngoingThis pilot study is testing a radioactive antibody called 124I-Humanized 3F8 to see how it travels through the body and attaches to tumors in people with melanoma, neuroblastoma, or sarcoma. Seven participants will receive the antibody and then have PET/CT scans at several time p…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Heart risk under the microscope: verapamil for cluster headaches
Knowledge-focused OngoingThis study looks at how often a common heart side effect (first-degree atrioventricular block) occurs when verapamil is used at high doses to prevent cluster headaches. Researchers will monitor 60 patients starting or already on verapamil, using ECGs and blood tests. The goal is …
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New study tracks nerve pain from breast cancer drug
Knowledge-focused OngoingThis study follows 36 people with HER2-positive breast cancer who are receiving the drug T-DM1. Researchers want to learn how often and how severely the drug causes nerve damage (peripheral neuropathy), such as numbness, tingling, or pain. Participants will report their symptoms …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Mayo clinic launches major brain disease tracking study
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to learn more about diseases that affect the brain, such as Parkinson's disease and different types of dementia. Researchers will follow 500 adults with symptoms of these conditions over time, using brain scans and genetic tests to see how the diseases progress. T…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Night pain in knee OA linked to nerve pain, study suggests
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at 150 people with knee osteoarthritis to see how often night pain and nerve pain (neuropathic pain) occur together. Researchers will use questionnaires and physical exams to measure pain and sleep quality. The goal is to better understand these pain types and th…
Sponsor: Bozyaka Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Could POTS be an autoimmune disorder? new study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study at Vanderbilt University Medical Center is looking at whether people with postural tachycardia syndrome (POTS) have higher levels of certain immune proteins that might affect their symptoms. Researchers will measure these proteins in blood samples and test how the hear…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New registry to track MG drug safety in 1,500 patients
Knowledge-focused ENROLLING_BY_INVITATIONThis registry will follow about 1,500 adults with myasthenia gravis (MG) to see how well current treatments work and how safe they are in real life. Doctors and patients will report data during routine visits. The goal is to better understand the disease and improve care.
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
500 NF1 patients join study to track skin tumors over 5 years
Knowledge-focused OngoingThis study follows 500 people with neurofibromatosis type 1 (NF1) to see how their skin tumors (called cutaneous neurofibromas) grow and change over time. Researchers use 3D whole-body photography to track tumor number and size each year. The goal is to better understand these tu…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Could antibodies be the key to understanding POTS?
Knowledge-focused OngoingThis study compares blood samples from 212 people with and without Postural Orthostatic Tachycardia Syndrome (POTS) to see if those with POTS have higher levels of certain antibodies. Researchers also want to know if these antibodies are more common in people whose POTS started a…
Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Immune cell showdown: autoimmune vs. infection vs. healthy
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at immune cells from people with autoimmune diseases (like lupus), people with infections, and healthy volunteers. Researchers want to understand how these cells differ and what makes them attack the body in autoimmune conditions. The study involves blood and bon…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Heart risks in adrenal tumor patients under the microscope
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 150 patients with functional adrenal tumors to see how their heart and blood pressure change before and after surgery. Researchers will use heart ultrasounds and blood pressure monitoring to understand recovery and risks. The goal is to help doctors choose bett…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:09 UTC
-
New study probes brain inflammation to unlock dementia mysteries
Knowledge-focused OngoingThis observational study looks at how brain inflammation contributes to frontotemporal lobar degeneration (FTLD), a group of disorders that cause dementia. Researchers will use advanced brain scans, blood tests, and spinal fluid analysis in 110 participants to find biomarkers tha…
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:38 UTC
-
Blood test could spot hidden tumors in NF1 patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to find blood-based biomarkers that signal the presence and size of plexiform neurofibromas in people with Neurofibromatosis type 1 (NF1). Researchers will collect blood samples and use whole-body MRI to compare biomarker levels in 200 participants with different …
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:08 UTC